
<html lang="en"     class="pb-page"  data-request-id="efd0331c-8a7b-4761-9137-99a7c3333db2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm061143k;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2007.50.issue-3"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides" /></meta><meta name="dc.Creator" content="Daniela  Fattori,*,†" /></meta><meta name="dc.Creator" content="Cristina  Rossi,†" /></meta><meta name="dc.Creator" content="Christopher I.  Fincham,†" /></meta><meta name="dc.Creator" content="Valerio  Caciagli,†" /></meta><meta name="dc.Creator" content="Fernando  Catrambone,†" /></meta><meta name="dc.Creator" content="Piero  D'Andrea,†" /></meta><meta name="dc.Creator" content="Patrizia  Felicetti,†" /></meta><meta name="dc.Creator" content="Martina  Gensini,‡" /></meta><meta name="dc.Creator" content="Elena  Marastoni,†" /></meta><meta name="dc.Creator" content="Rossano  Nannicini,‡" /></meta><meta name="dc.Creator" content="Marielle  Paris,†" /></meta><meta name="dc.Creator" content="Rosa  Terracciano,†" /></meta><meta name="dc.Creator" content="Alessandro  Bressan,†" /></meta><meta name="dc.Creator" content="Sandro  Giuliani,‡" /></meta><meta name="dc.Creator" content="Carlo A.  Maggi,‡" /></meta><meta name="dc.Creator" content="Stefania  Meini,‡" /></meta><meta name="dc.Creator" content="Claudio  Valenti,‡ and" /></meta><meta name="dc.Creator" content="Laura  Quartara‡" /></meta><meta name="dc.Description" content="Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B2 receptor antagonists (J. Med. Chem. 2006, 3602−3613). This work led to the discovery of ..." /></meta><meta name="Description" content="Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B2 receptor antagonists (J. Med. Chem. 2006, 3602−3613). This work led to the discovery of ..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="January 6, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm061143k" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-50-3-550" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(06)01143-5" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2007 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm061143k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm061143k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm061143k" /></link>
        
    
    

<title>Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm061143k" /></meta><meta property="og:title" content="Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kn00001.jpeg" /></meta><meta property="og:description" content=" Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B2 receptor antagonists (J. Med. Chem. 2006, 3602−3613). This work led to the discovery of MEN 15442, an antagonist with subnanomolar affinity for the human B2 receptor (hB2R), which also displayed significant and prolonged activity in vivo (for up to 210 min) against BK-induced bronchoconstriction in the guinea-pig at a dose of 300 nmol/kg (it), while demonstrating only a slight effect on BK-induced hypotension. Here we describe the further optimization of this series of compounds aimed at maximizing the effect on bronchoconstriction and minimizing the effect on hypotension, with a view to developing topically delivered drugs for airway diseases. The work led to the discovery of MEN 16132, a compound which, after intratracheal or aerosol administration, inhibited, in a dose-dependent manner, BK-induced bronchoconstricton in the airways, while showing minimal systemic activity. This compound was selected as a preclinical candidate for the topical treatment of airway diseases involving kinin B2 receptor stimulation.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm061143k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm061143k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm061143k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm061143k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm061143k&amp;href=/doi/10.1021/jm061143k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2007</span><span class="cit-fg-volume">, 50</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 550-565</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/50/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm061017g" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm061118e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB<sub>2</sub> Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Fattori">Daniela Fattori</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Rossi">Cristina Rossi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+I.++Fincham">Christopher I. Fincham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerio++Caciagli">Valerio Caciagli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Catrambone">Fernando Catrambone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piero++D%27Andrea">Piero D'Andrea</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrizia++Felicetti">Patrizia Felicetti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Gensini">Martina Gensini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Marastoni">Elena Marastoni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rossano++Nannicini">Rossano Nannicini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marielle++Paris">Marielle Paris</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosa++Terracciano">Rosa Terracciano</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Bressan">Alessandro Bressan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandro++Giuliani">Sandro Giuliani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlo+A.++Maggi">Carlo A. Maggi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Meini">Stefania Meini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Valenti">Claudio Valenti</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Quartara">Laura Quartara</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm061143k&amp;href=/doi/10.1021%2Fjm061143k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2007</span></span><span class="cit-volume">, 50</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 550–565</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 6, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 October 2006</li><li><span class="item_label"><b>Published</b> online</span>6 January 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2007</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm061143k" title="DOI URL">https://doi.org/10.1021/jm061143k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2007 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D550%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniela%2BFattori%252C%2BCristina%2BRossi%252C%2BChristopher%2BI.%2BFincham%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D50%26issueNum%3D3%26contentID%3Djm061143k%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BSulfonamide-Containing%2BBradykinin%2BhB2%2BReceptor%2BAntagonists.%2B2.%2BSynthesis%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2B%25CE%25B1%252C%25CE%25B1-Cycloalkylglycine%2BSulfonamides%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D565%26publicationDate%3DFebruary%2B2007">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm061143k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1750</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm061143k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel Sulfonamide-Containing Bradykinin hB2 Receptor Antagonists. 2. Synthesis and Structure−Activity Relationships of α,α-Cycloalkylglycine Sulfonamides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Fattori&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Rossi&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;I. Fincham&quot;},{&quot;first_name&quot;:&quot;Valerio&quot;,&quot;last_name&quot;:&quot;Caciagli&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Catrambone&quot;},{&quot;first_name&quot;:&quot;Piero&quot;,&quot;last_name&quot;:&quot;D'Andrea&quot;},{&quot;first_name&quot;:&quot;Patrizia&quot;,&quot;last_name&quot;:&quot;Felicetti&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Gensini&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Marastoni&quot;},{&quot;first_name&quot;:&quot;Rossano&quot;,&quot;last_name&quot;:&quot;Nannicini&quot;},{&quot;first_name&quot;:&quot;Marielle&quot;,&quot;last_name&quot;:&quot;Paris&quot;},{&quot;first_name&quot;:&quot;Rosa&quot;,&quot;last_name&quot;:&quot;Terracciano&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Bressan&quot;},{&quot;first_name&quot;:&quot;Sandro&quot;,&quot;last_name&quot;:&quot;Giuliani&quot;},{&quot;first_name&quot;:&quot;Carlo&quot;,&quot;last_name&quot;:&quot;A. Maggi&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Meini&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Quartara&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;50&quot;,&quot;pages&quot;:&quot;550-565&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm061143k&quot;},&quot;abstract&quot;:&quot;Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B2 receptor antagonists (J. Med. Chem. 2006, 3602−3613). This work led to the discovery of MEN 15442, an antagonist with subnanomolar affinity for the human B2 receptor (hB2R), which also displayed significant and prolonged activity in vivo (for up to 210 min) against BK-induced bronchoconstriction in the guinea-pig at a dose of 300 nmol/kg (it), while demonstrating only a slight effect on BK-induced hypotension. Here we describe the further optimization of this series of compounds aimed at maximizing the effect on bronchoconstriction and minimizing the effect on hypotension, with a view to developing topically delivered drugs for airway diseases. The work led to the discovery of MEN 16132, a compound which, after intratracheal or aerosol administration, inhibited, in a dose-dependent manner, BK-induced bronchoconstricton in the airways, while showing minimal systemic activity. This compound was selected &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm061143k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm061143k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm061143k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm061143k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm061143k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm061143k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm061143k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm061143k&amp;href=/doi/10.1021/jm061143k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm061143k" /></input><a href="/doi/pdf/10.1021/jm061143k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (522 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm061143k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm061143k%26sid%3Dliteratum%253Aachs%26pmid%3D17266207%26genre%3Darticle%26aulast%3DFattori%26date%3D2007%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BSulfonamide-Containing%2BBradykinin%2BhB2%2BReceptor%2BAntagonists.%2B2.%2BSynthesis%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2B%25CE%25B1%252C%25CE%25B1-Cycloalkylglycine%2BSulfonamides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D50%26issue%3D3%26spage%3D550%26epage%3D565%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/50/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Recently we reported on the design and synthesis of a novel class of selective nonpeptide bradykinin (BK) B<sub>2</sub> receptor antagonists (<i>J. Med. Chem.</i> 2006, 3602−3613). This work led to the discovery of MEN 15442, an antagonist with subnanomolar affinity for the human B2 receptor (hB2R), which also displayed significant and prolonged activity in vivo (for up to 210 min) against BK-induced bronchoconstriction in the guinea-pig at a dose of 300 nmol/kg (it), while demonstrating only a slight effect on BK-induced hypotension. Here we describe the further optimization of this series of compounds aimed at maximizing the effect on bronchoconstriction and minimizing the effect on hypotension, with a view to developing topically delivered drugs for airway diseases. The work led to the discovery of MEN 16132, a compound which, after intratracheal or aerosol administration, inhibited, in a dose-dependent manner, BK-induced bronchoconstricton in the airways, while showing minimal systemic activity. This compound was selected as a preclinical candidate for the topical treatment of airway diseases involving kinin B2 receptor stimulation. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm061143kAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone:  +39 06 91184522. Fax:  +39 06 9106137. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0a6e6c6b7e7e6578634a676f646b78636463277863696f7869626f24637e24">[email protected]</a> </p></span></div><div class="fnGroupItem" id="jm061143kAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Menarini Ricerche, Pomezia (Rome), Italy.</p></span></div><div class="fnGroupItem" id="jm061143kAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Menarini Ricerche, Florence, Italy.</p></span></div><div class="fnGroupItem" id="jm061143kn00001"><span><h4></h4></span><span><p class="first last">Abbreviations:  AcOH, acetic acid; AcCN, acetonitrile; BSA, <i>N</i>,<i>O</i>-bis-trimethylsilylacetamide; DIAD, diisopropyl azodicarboxylate; DIPEA, diisopropylethyl amine; DCM, dichloromethane; DMF, dimethylformamide; DMSO, dimethylsulfoxide; EDAC, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>‘-ethylcarbodiimide; EtOAc, ethyl acetate; Et<sub>2</sub>O, diethyl ether; EtOH, ethanol; HOAt, 7-aza-1-hydroxybenzotriazole; HOBt, 1-hydroxybenzotriazole; MeOH, methanol; NBS, <i>N</i>-bromosuccinimide; PyBOP, (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate; TFA, trifluoroacetic acid; THF, tetrahydrofuran; TMSCl, trimethylsilyl chloride.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bradykinin is a nonapeptide (BK:  Arg<sup><a onclick="showRef(event, 'jm061143kb00001'); return false;" href="javascript:void(0);" class="ref jm061143kb00001">1</a></sup>-Pro<sup><a onclick="showRef(event, 'jm061143kb00002'); return false;" href="javascript:void(0);" class="ref jm061143kb00002">2</a></sup>-Pro<sup><a onclick="showRef(event, 'jm061143kb00003'); return false;" href="javascript:void(0);" class="ref jm061143kb00003">3</a></sup>-Gly<sup><a onclick="showRef(event, 'jm061143kb00004'); return false;" href="javascript:void(0);" class="ref jm061143kb00004">4</a></sup>-Phe<sup><a onclick="showRef(event, 'jm061143kb00005'); return false;" href="javascript:void(0);" class="ref jm061143kb00005">5</a></sup>-Ser<sup><a onclick="showRef(event, 'jm061143kb00006'); return false;" href="javascript:void(0);" class="ref jm061143kb00006">6</a></sup>-Pro<sup><a onclick="showRef(event, 'jm061143kb00007'); return false;" href="javascript:void(0);" class="ref jm061143kb00007">7</a></sup>-Phe<sup><a onclick="showRef(event, 'jm061143kb00008'); return false;" href="javascript:void(0);" class="ref jm061143kb00008">8</a></sup>-Arg<sup><a onclick="showRef(event, 'jm061143kb00009'); return false;" href="javascript:void(0);" class="ref jm061143kb00009">9</a></sup>) generated in plasma and tissue by activation of kininogens and exerts its effects through the constitutively expressed B<sub>2</sub> receptor or through the induced B<sub>1</sub> receptor. </div><div class="NLM_p">In humans and guinea pigs, the kinin B<sub>2</sub> receptors are expressed in the upper and lower airways.<sup>1,2</sup> In humans, BK induces potent bronchoconstriction and cough when inhaled by asthmatic patients<sup>3</sup> and rhinitis-like symptoms when instilled into the nose.<sup>4</sup> Furthermore, BK is generated in human nasal secretions during rhinovirus infections<sup>5</sup> and allergic rhinitis.<sup>6</sup> On the basis of these findings, a potential therapeutic role for kinin B<sub>2</sub> receptor antagonists has been hypothesized in the treatment of airway inflammatory pathologies, such as chronic bronchial asthma<sup>7</sup> or perennial and seasonal allergic rhinitis.<sup>8</sup> In addition, a B<sub>2</sub> receptor is expressed also in the cardiovascular system, where kinins exert protective effects. Several studies have provided evidence suggesting that BK contributes to the antihypertensive and cardioprotective effects of angiotensin-converting enzyme inhibitors<sup>9</sup> and angiotensin II antagonists.<sup><a onclick="showRef(event, 'jm061143kb00010'); return false;" href="javascript:void(0);" class="ref jm061143kb00010">10</a></sup> On the basis of these considerations, it would be ideal to block B<sub>2</sub> receptors in the airways without affecting them at the cardiovascular level. </div><div class="NLM_p">We argued that the development of new, selective, human B<sub>2</sub> receptor (hB<sub>2</sub>R) antagonists for topical administration would be the best way of achieving the goal of airway selectivity. With this aim in mind, we undertook work on the sulfonamide moiety of Anatibant, the most advanced hB<sub>2</sub>R antagonist, which led to the discovery of MEN 15422 (Chart 1).<sup><a onclick="showRef(event, 'jm061143kb00011'); return false;" href="javascript:void(0);" class="ref jm061143kb00011">11</a></sup> In an in vivo assay in the guinea pig, the latter, at a dose of 300 nmol/kg, was able to lower the residual bronchoconstriction activity (Σ%)<sup><a onclick="showRef(event, 'jm061143kb00012'); return false;" href="javascript:void(0);" class="ref jm061143kb00012">12</a></sup> to 39 following a challenge with BK (10 nmol/kg iv); at the same dose Anatibant had a Σ% of 73 (Figure 1<a data-tab="pane-pcw-Figures" href="#jm061143kf00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kc00001" id="" class=" internalNav"></a>). However, at this dose, MEN 15422 had still a noticeable effect on BK-induced hypotension (Σ% 79), indicating that the further improvement is needed. This current paper describes our efforts to optimize the pharmacodynamic properties of our lead compound (lower dose, greater airway selectivity).<a class="ref internalNav" href="#jm061143kn00001" aria-label=""></a><div id="_i4"><figure id="jm061143kf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 In vivo activity of compounds <b>41</b>−<b>46</b> and reference compounds after intratracheal administration at 300 nmol/kg. For details, see the Experimental Section. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kc00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kc00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kc00001.jpeg" id="_i6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Competitive, Nonpeptidic hB<sub>2</sub> Receptor Antagonists Anatibant and MEN 15442 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kc00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kc00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">As a general working strategy, all compounds showing a p<i>K</i><sub>i</sub> ≥ 9.0 in a hB<sub>2</sub>R binding assay were assessed for their ability to antagonize a BK-induced functional response, that is, the accumulation of inositolphosphate (IP) as an index of the activation of the hB<sub>2</sub>R expressed in CHO cells (hp<i>A</i><sub>2</sub>). Promising candidates were subsequently screened in a bioassay for their ability to antagonize the BK-induced contraction of the guinea pig ileum longitudinal smooth muscle (GPI) to avoid any possible problems arising from species related selectivity when performing in vivo tests in the guinea pig. Compounds having a p<i>A</i><sub>2</sub> (IP) ≥ 8.7 and a p<i>A</i><sub>2</sub> (GPI) ≥ 9 were then tested in vivo, via intratracheal administration, for their effect on BK-induced bronchoconstriction and hypotension. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The compounds described in this study are shown in Tables 1−3<a class="ref showTableEvent internalNav" data-ID="jm061143kt00001" href="#jm061143kt00001"></a><a class="ref showTableEvent internalNav" data-ID="jm061143kt00002" href="#jm061143kt00002"></a><a class="ref showTableEvent internalNav" data-ID="jm061143kt00003" href="#jm061143kt00003"></a>, and the synthetic methods for their preparation are outlined in Schemes 1−7<a data-tab="pane-pcw-Figures" href="#jm061143kh00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00003" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00004" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00005" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00006" id="" class=" internalNav"></a>. Chlorosulfonic acid <b>1</b><sup>11</sup> was subjected to radical bromination under standard conditions (NBS, AIBN) to obtain benzylbromide <b>2</b>. Formation of the sulfonamides with the corresponding α,α-aminoacids was performed in two ways, either via a classical base-catalyzed reaction with the amino acid methyl ester or by the addition of the amino acid pretreated with BSA (<i>N</i>,<i>O</i>-<i>bis-</i>trimethylsilylacetamide). The resulting <a name="jm005000300551" id="jm005000300551"></a> methyl esters (<b>3a</b>, <b>3b</b>, and <b>3c</b>) or free acids (<b>3d</b>, <b>3e</b>, and <b>3f</b>) were reacted with 2,4-dimethyl-quinolin-8-ol in the presence of a base and, in the case of methyl esters, then subjected to basic hydrolysis to obtain acids <b>4a</b>−<b>f</b> (Scheme 1). These were coupled with either functionalized piperazines (<b>19</b>, <b>21</b>, <b>26</b>,<b> 38</b>, and <b>40</b>; Scheme 2, route a) or with a monoprotected piperazine residue (Scheme 2, route b). In the latter case, removal of the protecting group (Boc or Fmoc) gave intermediates <b>6</b>, which were coupled with the chosen acids. The carboxylic acids with suitably protected basic and/or charged groups were derived from <span class="smallcaps smallerCapital">l</span>-ornithine (Scheme 3), <span class="smallcaps smallerCapital">l</span>-β-lysine (Scheme 4), <span class="smallcaps smallerCapital">l</span>-lysine (Scheme 5), or simple ω-amino acids of differing chain lengths (Scheme 6). The functionalized piperazines were mainly two kinds:  dimethylamines (<b>9</b>, <b>18</b>, <b>19</b>, <b>24</b>, and <b>31</b>) generated via reductive amination with aq HCHO in the presence of H<sub>2</sub>/Pd or NaCNBH<sub>3</sub> or trimethylammonium salts (<b>10</b>, <b>12</b>, <b>14</b>, <b>21</b>, <b>26</b>, <b>29</b>, <b>32</b>, <b>34</b>, and <b>40</b>) obtained via treatment of the amines with <i>O</i>-methyl-<i>N</i>,<i>N</i>‘-diisopropylurea or dimethylsulfate. Finally, a guanidino moiety was introduced into compound <b>36</b> using 1,3-di-Boc-2-(trifluoromethylsulfonyl)guanidine (Goodman's reagent) and alkylated via a Mitsunobu reaction (Scheme 7). In all cases, removal of the protecting groups and HPLC purification gave the final products. <div id="_i8"><figure id="jm061143kh00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00001.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) NBS, AIBN, CCl<sub>4</sub>; (b) amino acid methyl ester, base; (c) amino acid, BSA, TMSCl, THF; (d) 2,4-dimethyl-quinolin-8-ol, KI, base; (e) LiOH, THF/H<sub>2</sub>O or NaOH, THF/H<sub>2</sub>O; (f) HCl/dioxane; (g) HCHO, BH<sub>3</sub>−CN resin, MeOH; (h) Ac<sub>2</sub>O, DIPEA, DMF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00002.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) EDAC, HOAt, R‘CO-piperazine; (b) HOAt or HOBt, EDAC, Boc-piperazine (<b>5a</b>−<b>5c</b>, <b>5e</b>, <b>5f</b>) or Fmoc-piperazine (<b>5d</b>); (c) HCl/dioxane; (d) piperidine, DMF; (e) R‘CO<sub>2</sub>H, EDAC, HOBt, DIPEA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00003.jpeg" id="_i11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) HCHO, H<sub>2</sub>, 10% Pd/C, MeOH; (b) <i>O</i>-methyl-<i>N</i>,<i>N</i>‘-diisopropylisourea, MeOH; (c) Me<sub>2</sub>SO<sub>4</sub>, NaOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00004.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) H<sub>2</sub>, 10% Pd/C, MeOH; (b) Goodman's reagent; (c) HCHO, NaCNBH<sub>3</sub>; (d) Fmoc-piperazine, EDAC, HOBt, DIPEA; (e) H<sub>2</sub>, 10% Pd/C, AcOH; (f) MeI; (g) piperidine/DMF; (h) HCl/dioxane.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00005.jpeg" id="_i13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) H<sub>2</sub>, 10% Pd/C, MeOH; (b) Me<sub>2</sub>SO<sub>4</sub>, NaOH; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCHO, NaCNBH<sub>3</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00006.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (b) Me<sub>2</sub>SO<sub>4</sub>, NaOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm061143kt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Binding and In Vitro Functional Activity on the hB<sub>2</sub> Receptor and Functional Activity on the Guinea-Pig Ileum (GPI) B<sub>2</sub> Receptor for Compounds <b>41</b>−<b>46</b></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143ku00001a.gif" alt="" id="_i15" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> p<i>K</i><sub>i</sub> for inhibition of specific binding of [<sup>3</sup>H]-BK to hB<sub>2</sub> receptor in stably transfected CHO cells membrane preparations.<i><sup>b</sup></i><sup></sup> p<i>A</i><sub>2</sub> for the hB<sub>2</sub>-mediated accumulation of inositol monophosphate in stably transfected CHOdhfr-/hB<sub>2</sub>R cells.<i><sup>c</sup></i><sup></sup> p<i>A</i><sub>2</sub> for the antagonism of BK-induced contractile responses in guinea-pig ileum longitudinal smooth muscle. For details see the Experimental Section.</p></div></div><div class="NLM_table-wrap" id="jm061143kt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Binding and In Vitro Functional Activity on the hB<sub>2</sub> Receptor of Compounds <b>47</b>−<b>67</b></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143ku00002a.gif" alt="" id="_i16" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Table 1.<i><sup>b</sup></i><sup></sup> See Table 1. For details see the Experimental Section.</p></div></div><div class="NLM_table-wrap" id="jm061143kt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Binding and In Vitro Functional Activity on the hB<sub>2</sub> Receptor of Compounds <b>68</b>−<b>76</b></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143ku00003a.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Table 1.<i><sup>b</sup></i><sup></sup> See Table 1. For details see the Experimental Section. </p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initially we decided to explore the effect, in a small set of analogues, of replacing the α,α-dimethylglycine group of MEN 15422 with the slightly more bulky α,α-cyclopentaneglycine residue. Comparison of the in vitro activity of these compounds (<b>41</b>−<b>46</b>) revealed that the cyclopentaneglycine derivatives, generally, had similar, or slightly lower, binding affinities but slightly higher potencies in the functional assay on the hB<sub>2</sub> receptor (Table 1). These compounds, as well as all the others mentioned in this paper, had a p<i>A</i><sub>2</sub> (GPI) ≥ 9. </div><div class="NLM_p">The in vivo activity of the compounds in the guinea pig was measured after intratracheal administration (300 nmol/kg), followed 5 min later by a BK challenge (10 nmol/kg iv, repeated every 30 min for 210 min). The pulmonary insufflation pressure and the blood pressure were monitored as a measure of BK-induced bronchoconstriction and BK-induced hypotension, respectively. The results are shown in Figure 1. Under these experimental conditions, all the compounds tested were more active than Anatibant and all showed greater activity at the pulmonary B<sub>2</sub> receptors compared to that at the cardiovascular receptors, though for some compounds, for example, <b>45</b>, this too was appreciable (Σ% 51). In two out of the three cases examined, the cyclopentaneglycine derivatives showed better inhibition of bronchoconstriction than their dimethylglycine counterparts (see Figure 1, <b>41</b> vs <b>44</b> and <b>43</b> vs <b>46</b>). </div><div class="NLM_p">This small improvement led us to investigate further the new series, and several modifications were made to the substituents on the piperazine ring (Table 2). Efforts focused on modifying the structure of these substituents so that, following intratracheal administration, they would help the molecule to remain “stuck” <a name="jm005000300552" id="jm005000300552"></a> to the surface of the respiratory tract,<sup>14</sup> with a minimal amount being released into circulation to interact with the cardiovascular receptors. A similar strategy has been used for the muscarinic receptor antagonists ipratropium, flutropium, and tiotropium.<sup>15</sup> Thus, it was decided to increase the polarity of the molecule via the introduction of positive charges through the use of very basic functional groups (protonated at physiological pH) and quaternary ammonium salts. These groups have the added advantage of rendering the molecules poorly bioavailable thus avoiding absorption of the compounds following accidental ingestion during intratracheal or aerosol administration. </div><div class="NLM_p">Carboxylic acids containing amines, ammonium salts, and guanidines at varying distances and geometries were linked to the piperazine moiety (Table 2). All the new compounds, with the single exception of compound <b>50</b>, showed subnanomolar binding affinities, and all had good activity in the functional test (p<i>A</i><sub>2</sub> ≥ 8.2). Best of all was ammonium salt <b>63</b>, with a p<i>K</i><sub>i</sub> of 10.3 and a p<i>A</i><sub>2</sub> of 9.3. The combination of a primary amine and a quaternary ammonium salt at the correct distance from one another appeared to be the key for both high binding affinity and high antagonist potency (compound <b>63</b> vs compounds <b>49</b> and <b>61</b>). The majority of the compounds were then screened in vivo, at a dose of 100 nmol/kg, to assess their potency and selectivity of action in inhibiting bronchoconstriction over hypotension (Figure 2<a data-tab="pane-pcw-Figures" href="#jm061143kf00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm061143kh00007" id="" class=" internalNav"></a>a). At this dose, only compound <b>63</b> showed very good inhibition of BK-induced bronchoconstriction (Σ% 24), with a minimal effect on BK-induced hypotension. <div id="_i19"><figure id="jm061143kf00002" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00002.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 In vivo activity of compounds <b>49</b>−<b>67</b> after intratracheal administration at 100 nmol/kg. For details, see the Experimental Section; <b>66</b> and <b>67</b> were tested at 300 nmol/kg. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kh00007" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00007.jpeg" id="_i21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Goodman's reagent; (b) DIAD, PPh<sub>3</sub>, 3-dimethylaminopropanol; (c) HCl/dioxane; (d) MeI.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Therefore, we decided to use this molecule as the starting point for a final set of compounds in which a heteroatom was inserted into the central cyclic α,α-disubstituted amino acid to increase the polar surface area in this region of the molecule (Table 3). Again, all the compounds showed outstanding binding affinities, and the introduction of a tetrahydropyran ring (<b>72</b>) significantly enhanced the p<i>A</i><sub>2</sub> in comparison to compound <b>63</b>. Those new compounds with a p<i>A</i><sub>2</sub> ≥ 9 were tested in vivo, and this confirmed the excellent activity of compound <b>72</b> (MEN 16132; Figure 3<a data-tab="pane-pcw-Figures" href="#jm061143kf00003" id="" class=" internalNav"></a>). The activity of this compound remained high even at lower doses; at 30 nmol/kg it showed a Σ% of 39 against BK-induced bronchoconstriction, and at an even lower dose (10 nmol/kg, i.t.) it maintained a Σ% of 63, while any significant effect on BK-induced hypotension was undetectable (Figure 4<a data-tab="pane-pcw-Figures" href="#jm061143kf00004" id="" class=" internalNav"></a>). At all three doses the inhibitory effect lasted for at least 210 min. <div id="_i22"><figure id="jm061143kf00003" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00003.jpeg" id="_i23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 In vivo activity of compounds <b>68</b>, <b>70</b>, and <b>72</b> after intratracheal administration at 100 nmol/kg. For details, see the Experimental Section. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm061143kf00004" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00004.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 In vivo activity of compound <b>72</b> after intratracheal administration on bronchoconstriction and hypotension induced by repeated challenges with BK (10 nmol/kg iv) in anaesthetized guinea pigs.<sup>16</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">All the compounds reported in this paper were also tested for their affinity at the hB1 receptor and all showed a p<i>K</i><sub>i</sub> value of <5. Finally, given the presence of a trimethylammonium moiety in MEN 16132 (<b>72</b>), the compound was tested, at 1 μM, for any activity on the muscarinic or nicotinic receptors; none was found. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper we have described the extensive work carried out on MEN 15422, the lead compound from our first paper.<sup>11</sup> Changes to the amino acid used to form the central sulfonamide unit and to the nature and distribution of the polar groups in the terminal chain produced a compound, MEN 16132 (<b>72</b>), which was 100× more active in vivo. This new molecule, when administered locally, was a potent and long lasting antagonist of BK-induced bronchoconstriction in the airways, devoid of any significant effects on BK-induced hypotension.<sup>16</sup> It could be potentially useful in the treatment of chronic airway diseases involving the proinflammatory activity of BK and is under study. Additional pharmacological results will be reported in due course. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>(A) Chemistry.</b> Commercial chemicals and solvents were of reagent grade and used without further purification. </div><div class="NLM_p">Merck silica gel (Kieselgel 60) was used for analytical thin-layer chromatography (TLC, F254 plates) and flash chromatography (230−400 mesh). </div><div class="NLM_p">Purity was evaluated by analytical HPLC using a 600 E Waters pump coupled to a Jasco 875 UV detector and a Merck-Hitachi D-2500 integrator, or a system comprising a Jasco PU-980 pump, LG-980−02 gradient unit, a UV-975 UV/vis detector, and a Merck-Hitachi D-2500 integrator, a Beckman System Gold apparatus, or an Agilent 1100 analytic HPLC system. The solvents were (A) water + 0.1% TFA and (B) AcCN + 0.1% TFA, flow 1 mL/min. </div><div class="NLM_p">System A:  Column Vydac RP-18, 5 μm, 250 × 4.6 mm, λ = 220 nm; from 95% to 20% solvent (A) in 25 min. System B:  Column Symmetry 300 RP-18, 250 × 4.6 mm, λ = 220 or 254 nm; from 80% to 20% solvent (A) in 20 min. System C:  Column Agilent Zorbax Eclipse XDB C8, 5 μm, 150 × 4.6 mm; λ = 210, 240 nm; from 80% to 20% solvent (A) in 20 min. System D:  column Jupiter RP-18, 5 μm, 150 × 4.6 mm, λ = 210, 240 nm; from 80% to 20% solvent (A) in 20 min. </div><div class="NLM_p">Preparative reverse phase HPLC was performed on a Waters 600E apparatus with a Jasco 874 UV detector or on a Waters Delta-Prep 3000 apparatus. The mobile phases were the same as for the analytical systems. Gradient elution was employed. The columns used were a SymmetryPrep C18, 7 μm, 19 × 300 mm, a Hibar <a name="jm005000300553" id="jm005000300553"></a> Lichrosorb RP-18, 7 μm, 25 × 250 mm, a Vydac C18, 10 μm, 22 × 250 mm or Jupiter, 15 μm, 250 × 21.2 mm. Peak detection was at 220 and 254 nm. Chemical yields are not optimized. </div><div class="NLM_p">NMR experiments were recorded on a Varian Gemini 200 mod. J200 HC, a Varian 300 MHz spectrometer (equipped with a 5 mm inverse probe), a Bruker Avance 400 MHz, or a Bruker Avance 600 MHz machine and are referenced to residual solvent signals:  CDCl<sub>3</sub> (δ 7.26) or DMSO-<i>d</i><sub>6</sub> (δ 2.49). Chemical shifts are reported in δ units (parts per million) and are assigned as singlets (s), doublets (d), doublets of doublets (dd), triplets (t), quartet (q), quintet (quin), multiplets (m), broad signals (br), or very broad signals (v br). Coupling constants (<i>J</i>) are reported in hertz (Hz). </div><div class="NLM_p">Mass spectra were recorded using a Waters Alliance 2795 HPLC system fitted with a UV-PDS 996 diode array detector, a ZMD mass spectrometer, and a GL Science Inertsil ODS-3 column (50 × 3 mm, 3 μm) or a ThermoFinnigan LCQ equipped with APCI or ESI source. </div><div class="NLM_p"><b>1-(3-Bromomethyl-2,4-dichloro-benzenesulfonylamino)-cyclopentanecarboxylic Acid </b><b>Methyl Ester (3a).</b> A mixture of <b>2</b> (150 mg, 0.445 mmol), 1-aminocyclopentancarboxylic acid methyl ester (87 mg, 0.490 mmol), and K<sub>2</sub>CO<sub>3</sub> (150 mg, 0.980 mmol) in DMF (15 mL) was stirred at room temperature for 18 h. At the end of the reaction (TLC control) the solution was diluted with water (150 mL) and extracted with EtOAc (3 × 50 mL). The organic layer was washed with 1 N HCl (3 × 50 mL), water (50 mL), and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a solid (100 mg) as a mixture of <b>3a </b>and the corresponding benzyl chloride in a ratio of 3:7. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 8.06−7.97 (1H, m), 7.54−7.48 (1H, m), 5.44 (1H, s), 4.94 (1.4H, s, CH<sub>2</sub>Cl), 4.82 (0.6H, s, CH<sub>2</sub>Br), 3.66−3.60 (3H, m), 2.52−2.03 (2H, m), 2.01−<a name="jm005000300554" id="jm005000300554"></a> 1.86 (2H, m), 1.80−1.51 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>BrCl<sub>2</sub>NO<sub>4</sub>S, 442.9; found, 460.8, 462.9, 464.8 [M + NH<sub>4</sub>]<sup>+</sup>. MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>Cl<sub>3</sub>NO<sub>4</sub>S, 399.0; found, 416.9, 419.0, 421.0 [M + NH<sub>4</sub>]<sup>+</sup>. HPLC purity:  system A, <i>t</i><sub>R</sub> 17.24 min (68.4%), 17.62 min (27.0%). </div><div class="NLM_p"><b>4-(3-Bromomethyl-2,4-dichloro-benzenesulfonylamino)-tetrahydro-pyran-4-carboxylic </b><b>Acid Methyl Ester (3b).</b> A solution of 5% NaHCO<sub>3</sub> (53 mL, 31.5 mmol) was added at a rate of 10 mL/h to a solution of the sulfonyl chloride <b>2</b> (2.91 g, 8.61 mmol) and the 4-amino-tetrahydropyran-4-carboxylic acid methyl ester hydrochloride (2.059 g, 10.52 mmol) in AcCN/water 10:1 (58.3 mL) at 5 °C. Stirring was continued at this temperature for 19.5 h, after which time HPLC analysis showed almost complete consumption of the sulfonyl chloride. The AcCN was removed in vacuo, the residue was diluted with water (80 mL), and the mixture was filtered under reduced pressure. The solid was washed with water (3×), air-dried for 30 min, then transferred to a tared flask and dried under high vacuum to constant weight to give <b>3b</b> as an off-white solid in a 3:1 mixture with the corresponding benzyl chloride (2.981 g, 75% yield). HPLC purity:  system B, <i>t</i><sub>R</sub> 17.46 min (12.4%), 17.88 min (83.8%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 7.99−7.91 (1H, m), 7.53−7.46 (1H, m), 5.30 (1H, br s), 4.94 (0.5H, s, CH<sub>2</sub>Cl), 4.81 (1.5H, s, CH<sub>2</sub>Br), 3.71−3.49 (7H, m), 2.25−2.07 (2H, m), 1.99−1.81 (2H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>BrCl<sub>2</sub>NO<sub>5</sub>S, 458.93; found, 460.1, 462.1, 464.1 [M + H]<sup>+</sup>. MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>Cl<sub>3</sub>NO<sub>5</sub>S, 414.98; found, 438.3, 440.1 [M + Na]<sup>+</sup>. HPLC purity:  system B, <i>t</i><sub>R</sub> 17.46 min (12.4%), 17.88 min (83.8%). </div><div class="NLM_p"><b>4-(3-Bromomethyl-2,4-dichloro-benzenesulfonylamino)-tetrahydro-thiopyran-4-carboxylic </b><b>Acid Methyl Ester (3c).</b> A solution of 1-amino-tetrahydrothiopyran carboxylic acid methyl ester hydrochloride (100 mg, 0.47 mmol) in 5% NaHCO<sub>3</sub> (0.7 mL) was added to a solution of sulfonyl chloride <b>2</b> (132 mg, 0.39 mmol) in AcCN (2 mL). The resulting mixture was stirred at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was dissolved in EtOAc, washed with 1 M KHSO<sub>4</sub> (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to obtain <b>3c</b> (88 mg) together with the corresponding benzyl chloride in the ratio 7:3 (50% yield). MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub><a name="jm005000300555" id="jm005000300555"></a> BrCl<sub>2</sub>NO<sub>4</sub>S<sub>2</sub>, 474.9; found, 492.9, 495.0, 496.9 [M + NH<sub>4</sub>]<sup>+</sup>. HPLC purity:  system B <i>t</i><sub>R</sub> 16.21 min (16.3%), 16.54 min (77.4%). </div><div class="NLM_p"><b>4-(3-(Bromomethyl)-2,4-dichloro-phenylsulfonamido)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)piperidine-4-</b><b>carboxylic Acid (3d).</b> A suspension of 4-Boc-1,1-aminopiperidinylcarboxylic acid (195 mg, 0.80 mmol) in dry THF (2.4 mL) was stirred at reflux temperature under nitrogen, and BSA (0.59 mL, 2.4 mmol) and TMSCl (0.31 mL, 2.4 mmol) were added. Refluxing was continued for an additional 2 h until dissolution of the amino acid was complete. Then a solution of sulfonyl chloride <b>2</b> (134 mg, 0.40 mmol) in dry THF (3 mL) was added dropwise with stirring. At the end of the reaction (HPLC control, RP-C18), the mixture was diluted with MeOH/H<sub>2</sub>O (1:1) and concentrated in vacuo to afford an oily yellow residue. This was diluted with EtOAc, washed with water (2×) and 1 M NaHSO<sub>4</sub> (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to afford an oil that solidified upon drying. This solid consisted of a mixture of <b>3d</b> and the corresponding benzyl chloride in a 4:1 mixture (83 mg, 41% yield). It was dissolved in acetone/DMF (1:2; 1.6 mL), NaBr (130 mg, 1.27 mmol) was added, and it was stirred at room temperature to convert the benzyl chloride into the benzyl bromide. At the end of the reaction (HPLC control), the solvent was distilled off in vacuo, the residue was dissolved in EtOAc, washed with water (4×), and dried over Na<sub>2</sub>SO<sub>4</sub> to obtain crude <b>3d</b> (86 mg), which was used as such in the following reaction. MS <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>23</sub>BrCl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S, 543.98; found, 542.8, 544.8, 546.8 [M − H<sup>+</sup>]<sup>-</sup>. HPLC purity:  system B (100−0% A in 30 min), <i>t</i><sub>R</sub> 21.00 min (20.0%), 21.26 min (80.0%). </div><div class="NLM_p"><b>1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cyclopenta</b><b>necarboxylic Acid (4a).</b> A solution of 2,4-dimethyl-quinolin-8-ol (42 mg, 0.24 mmol), <b>3a</b> (and the corresponding benzyl chloride in the ratio 3:7; 100 mg, 0.24 mmol), KI (43 mg, 0.26 mmol), and K<sub>2</sub>CO<sub>3</sub> (74 mg, 0.48 mmol) in dry acetone (10 mL) was refluxed for 7 h under nitrogen. At the end of the reaction (HPLC control), the mixture was poured over acetate buffer at pH 4.2 (100 mL) and extracted with EtOAc (3 × 50 mL). The organic layers were washed with water (3 × 70 mL) and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford 1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonyl-amino]-cyclopentanecarboxylic acid methyl ester (100 mg). A portion of this material (50 mg, 0.093 mmol) was dissolved in THF/MeOH/water (3:2:1; 6 mL) together with LiOH (24 mg, 0.1 mmol), and the resulting mixture was refluxed for 4 h. At the end of the reaction (HPLC control), the reaction was cooled to room temperature, the organic solvents were removed in vacuo, and the residue was diluted with water (10 mL). The pH was made acidic (ca. 5) by the cautious addition of 1 N HCl, and the solution was extracted with EtOAc (3 × 25 mL). The organic extracts were combined, washed with water (3 × 30 mL) and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford crude <b>4a</b> (41 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 8.13 (1H, d, <i>J</i> = 8.6 Hz), 7.68−7.50 (3H, m), 7.25 (1H, d, <i>J</i> = 7.8 Hz), 7.21 (1H, s), 5.80 (1H, s), 5.60 (2H, <a name="jm005000300556" id="jm005000300556"></a> s), 2.71 (3H, s), 2.58 (3H, s), 2.24−1.57 (8H, m). HPLC purity:  system A, 80.0%, <i>t</i><sub>R</sub> 10.07 min. </div><div class="NLM_p"><b>4-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-tetrahydro</b><b>-pyran-4-carboxylic Acid (4b).</b> 2,4-Dimethyl-quinolin-8-ol (2.253 g, 13.02 mmol) was dissolved in a 1.5 M solution of Bu<sub>4</sub>NOH (8.6 mL, 13 mmol) within 30 min. The resulting intense orange solution was added to Bu<sub>4</sub>NBr (347 mg, 1.08 mmol) and compound <b>3b</b> (as a 4:1 mixture with the corresponding benzyl chloride; 4.88 g, 10.8 mmol) in AcCN (20 mL). The mixture immediately turned green, and after about 4 h, a white solid separated from the solution. The course of the reaction was monitored by HPLC. After 24 h, the mixture was diluted with water (50 mL) and filtered, and the resulting solid was washed with water (100 mL), petroleum ether (15 mL), and MeOH (15 mL) and then dried in vacuo to yield the desired compound in the form of methyl ester (4.68 g). A batch of the methyl ester so obtained (5.46 g, 9.86 mmol) was suspended in AcCN (50 mL), and the mixture was heated to reflux. A 15% aq NaOH solution (52 mL, 197 mmol) was added, and complete solution occurred to give a biphasic system, which was refluxed for 24 h. At the end of the reaction (HPLC control), the mixture was cooled to room temperature and concentrated in vacuo to remove the AcCN, and the resulting cloudy solution was carefully acidified with 4 N HCl to pH 4−5. After stirring for 1 h, a fine white precipitate formed, which was filtered off, washed with water (100 mL) and Et<sub>2</sub>O (30 mL), and dried in vacuo to afford <b>4b</b> in 97% yield (5.45 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.64 (1H, br s), 8.03 (1H, d, <i>J</i> = 8.8 Hz), 7.75 (1H, d, <i>J</i> = 8.8 Hz), 7.67 (1H, d, <i>J</i> = 8.3 Hz), 7.46 (1H, dd, <i>J</i> = 8.3, 8.3 Hz), 7.37 (1H, d, <i>J</i> = 8.3 Hz), 7.30 (1H, s), 5.58 (2H, s), 3.50−3.38 (2H, m), 3.35−3.10 (2H, m), 2.64 (3H, s), 2.56 (3H, s), 1.90−1.75 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S, 538.1; found, 539.2, 541.2 [M + H]<sup>+</sup>. HPLC purity:  system B, 95.0%, <i>t</i><sub>R</sub> 11.63 min. </div><div class="NLM_p"><b>4-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-tetrahydro</b><b>-thiopyran-4-carboxylic Acid (4c).</b> A mixture of 2,4-dimethyl-quinolin-8-ol (35 mg, 0.20 mmol) and NaH (6.0 mg, 0.24 mmol) in DMF (3 mL) was stirred at room temperature for 45 min. Then a solution of <b>3c</b> (and the corresponding benzyl chloride in ratio 7:3; 91 mg, 0.20 mmol) and KI (60 mg, 0.40 mmol) in DMF (3 mL) was added dropwise. At the end of the reaction (HPLC control), the solvent was distilled off in vacuo, and the residue was dissolved in EtOAc. The organic solution was washed with pH 4.2 buffer (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give an orange solid (88 mg, 78% yield). This was dissolved in dioxane (3.0 mL) and heated to 100 °C, and a 5% aq NaOH solution (2.9 mL) was added while stirring. At the end of the reaction (HPLC control), the solution was concentrated in vacuo, and the orange residue was partitioned between EtOAc and pH 4.2 buffer. The two phases were separated, and the organic one was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to obtain <b>4c</b> (61 mg, 72% yield) as a white solid. MS <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub>, 554.05; found, 555.0, 557.0 [M + H]<sup>+</sup>. HPLC purity:  system B, 85%; <i>t</i><sub>R</sub> 10.43 min. </div><div class="NLM_p"><b>4-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-piperidine</b><b>-1,4-dicarboxylic Acid Mono-</b><b><i>tert</i></b><b>-butyl Ester (4d).</b> A mixture of 1,1-dimethyl-quinolin-8-ol (28 mg, <a name="jm005000300557" id="jm005000300557"></a> 0.16 mmol) and LiOH (10 mg, 0.4 mmol) in dry AcCN (2.5 mL) was stirred at room temperature for 1.5 h under nitrogen. Then a solution of crude <b>3d</b> (86 mg, 0.16 mmol) in AcCN/DMF (2:1) (2 mL) was added dropwise, and the resulting mixture was stirred at room temperature. At the end of the reaction (HPLC control), MeOH/water (1:1; 3 mL) was added, stirring was continued for an additional 15 min, and then the solvents were distilled off in vacuo. The residue was partitioned between EtOAc and pH 4.2 buffer. The two phases were separated, and the organic one was washed again with buffer (5×). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was triturated with Et<sub>2</sub>O to afford crude <b>4d</b> (70 mg, 70% yield). MS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>33</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>7</sub>S, 637.14; found, 638.1, 640.0 [M + H]<sup>+</sup>. HPLC purity:  system B, (100−0% A in 30 min), 70%, <i>t</i><sub>R</sub> 17.59 min. </div><div class="NLM_p"><b>2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-</b><b><i>N</i></b><b>-[1-(piperazine-1-carbonyl)-cyclope</b><b>ntyl]-benzenesulfonamide (6a).</b> EDAC (981 mg, 5.12 mmol) and HOBt (629 mg, 5.12 mmol) were added to a solution of acid <b>4a</b> (2.43 g, 4.66 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) stirred in an ice bath. The resulting mixture was stirred for an additional hour, then <i>N</i>-Boc-piperazine (697 mg, 5.12 mmol) and DIPEA (0.88 mL, 5.12 mmol) were added, and stirring was continued at room temperature overnight. Then the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with 0.1 N KHSO<sub>4</sub> (50 mL), 0.1 N NaOH (50 mL), and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was purified by flash chromatography to give the Boc-protected derivative in 99% purity. This was suspended in EtOAc (15 mL), and 4 N HCl in dioxane (20 mL) was added dropwise while stirring at room temperature. At the end of the reaction (HPLC control), the mixture was concentrated in vacuo, dissolved in water, and lyophilized to give <b>6a</b> (2.15 g, 73% yield) as a white solid in the form of the hydrochloride salt. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 8.94 (2H, s), 8.7 (s, 1H), 8.34 (1H, br s), 8.04−8.01 (1H, d), 7.83−7.81 (1H, d), 7.61−7.45 (4H, m), 5.56 (2H, s), 3.16 (4H, br s), 2.75 (3H, s), 2.69 (3H, s), 2.65 (3H, s), 1.93 (2H, m), 1.73 (2H, m), 1.42 (4 H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>32</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>4</sub>S, 591.56; found, 592.2 [M + H]<sup>+</sup>. HPLC purity:  system B (100−0% A in 30 min), 94%, <i>t</i><sub>R</sub> 10.37 min. </div><div class="NLM_p"><b>2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-</b><b><i>N</i></b><b>-[4-(piperazine-1-carbonyl)-tetrahy</b><b>dro-pyran-4-yl]-benzenesulfonamide (6b).</b> EDAC (51 mg, 0.27 mmol) was added to a chilled solution of acid <b>4b</b> (105 mg, 0.195 mmol) and HOAt (37 mg, 0.27 mmol) in DCM (6.0 mL). The resulting mixture was stirred for 30 min at 0 °C and then <i>N</i>-Boc-piperazine (66 mg, 0.35 mmol) was added. Stirring was continued at 0 °C for 30 min then at room temperature. At the end of the reaction (HPLC control), the DCM <a name="jm005000300558" id="jm005000300558"></a> was removed in vacuo, and the residue was partitioned between EtOAc (50 mL) and pH 4.2 buffer (50 mL). The layers were separated, and the organic phase was washed with buffer (50 mL). The aqueous washes were combined and re-extracted with EtOAc (50 mL), then the organic extracts were combined and washed with 5%NaHCO<sub>3</sub> (2 × 50 mL) and brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the filtrate was concentrated in vacuo to give crude <b>5b</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 8.02 (1H, d, <i>J</i> = 8.7 Hz), 7.64 (1H, d, <i>J</i> = 8.3 Hz), 7.50 (1H, d, <i>J</i> = 8.6 Hz), 7.39 (1H, t, <i>J</i> = 8.0 Hz), 7.20 (1H, d, <i>J</i> = 7.6 Hz), 7.15 (1H, s), 5.73 (2H, s), 5.52 (1H, s), 3.87−3.69 (4H, m), 3.63−3.43 (8H, m), 2.69 (3H, s), 2.64 (3H, s), 2.21−2.10 (2H, m), 1.65−1.52 (2H, m), 1.47 (9H, s). MS <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>40</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>7</sub>S<sub>2</sub>, 706.2; found, 707.2 [M + H]<sup>+</sup>. HPLC purity:  system B, 95.9%, <i>t</i><sub>R</sub> 15.22 min. HCl/dioxane (4 N, 4 mL) was added at room temperature to a solution of <b>5b</b> (138 mg, 0.195 mmol) in DCM (4 mL). At the end of the reaction (HPLC control), the solvents were removed in vacuo, and the residue was triturated with Et<sub>2</sub>O, filtered, washed with Et<sub>2</sub>O, and dried under a stream of N<sub>2</sub> to give <b>6b</b> (131 mg, 98%) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.73−9.50 (2H, m), 8.92 (1H, s), 8.46−8.12 (4H, m), 7.34−7.08 (2H, m), 5.68 (2H, br s), 4.15−3.77 (4H, m), 3.27−2.97 (6H, m), 2.83 (6H, br s), 1.98−1.77 (2H, m), 1.74−1.54 (2H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>4</sub>S, 606.15; found, 607.2, 609.2 [M + H]<sup>+</sup>. HPLC purity:  system B, 94.9%, <i>t</i><sub>R</sub> 9.46 min. </div><div class="NLM_p"><b>2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-</b><b><i>N</i></b><b>-[4-(piperazine-1-carbonyl)-tetrahy</b><b>dro-thiopyran-4-yl]-benzenesulfonamide (6c).</b> A solution of <b>4c</b> (45 mg, 0.083 mmol) and DIPEA (28 μL, 0.083 mmol) in DMF (2 mL) was stirred at room temperature. PyBOP (43 mg, 0.083 mmol) was added, followed by <i>N</i>-Boc-piperazine (15 mg, 0.083 mmol). At the end of the reaction (HPLC control), the solvent was distilled off in vacuo, and the orange residue was dissolved in EtOAc and washed with acetate buffer, pH 4.2 (3×). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to obtain crude <b>5c</b> (45 mg). MS <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>40</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S<sub>2</sub>, 722.18; found, 723.1, 725.1 [M + H]<sup>+</sup>. This crude product was dissolved in TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1; 2 mL) and stirred at room temperature. After 1 h, Et<sub>2</sub>O was added with stirring and a white solid precipitated. This was filtered off and dried under nitrogen to give crude <b>6c</b> as trifluoroacetate salt (26 mg), which was used as such without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>32</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>4</sub>S<sub>2</sub>, 622.12; found, 623.1, 625.1 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>4-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-4-(piperaz</b><b>ine-1-carbonyl)-piperidine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (6d).</b> A solution of <b>4d</b> (70 mg, 0.11 mmol) in DMF (3 mL) was stirred at room temperature. EDAC (25 mg, 0.13 mmol) and HOBt (18 mg, 0.13 mmol) were added. Fmoc-piperazine hydrochloride (38 mg, 0.110 mmol) was dissolved in DMF (1 mL), DIPEA was added (0.04 mL, 0.26 mmol), and the resulting solution was added dropwise to the solution of the active ester. The resulting mixture was stirred overnight. The solvents were distilled off in vacuo, and the residue was partitioned between EtOAc and pH 4.2 buffer. The organic layer was washed with buffer (2×) and then dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and triturated with Et<sub>2</sub>O to obtain crude <b>5d</b> as a white solid (76 mg, 75% yield). MS <i>m</i>/<i>z</i> calcd for C<sub>48</sub>H<sub>51</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>8</sub>S, 927.28; found, 928.2, 930.2 [M + H]<sup>+</sup>. A solution of <b>5d</b> (76 mg, 0.081 mmol) in piperidine/DMF 1:10 (3 mL) was stirred at room temperature for 1 h. The solution was concentrated in vacuo, and the resulting yellow oil was triturated with Et<sub>2</sub>O to obtain <b>6d</b> as a white solid (47 mg, 81% yield). MS <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>41</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>6</sub>S, 705.22; found, 706.2, 708.2 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-</b><b><i>N</i></b><b>-[1-methyl-4-(piperazine-1-carbony</b><b>l)-piperidin-4-yl]-benzenesulfonamide (6e).</b> A solution of <b>4d</b> (173 mg, 0.27 mmol) in dry dioxane (1 mL) was cooled to 0 °C, 4 N HCl in dioxane (10 mL) was added, and the mixture was warmed to room temperature. At the end of the reaction (2 h, HPLC control), the solvents were distilled off under reduced pressure and the residue was triturated with Et<sub>2</sub>O (3×) to obtain crude 4-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-piperidine-4-carboxylic acid as the hydrochloride salt (176 mg). A portion of this product (50 mg, 0.08 mmol) was dissolved in MeOH (4.5 mL), and 37% aq HCHO (30.7 μL, 0.41 mmol) was added, together with NaCNBH<sub>3</sub> polystyrene resin (38 mg, 4.3 mmol/gr, 0.16 mmol), and stirring was continued at room temperature. At the end of the reaction (HPLC control), the resin was filtered off and the residual solution was concentrated in vacuo, with the help of toluene (4×), to obtain crude <b>4e</b>. </div><div class="NLM_p">Crude <b>4e</b> (40 mg, 0.07 mmol) in dry DMF (1 mL) was stirred at room temperature. HOAt (98 mg, 0.07 mmol), DCC (14.8 mg, 0.07 mmol), and Boc-piperazine (13 mg, 0.07 mmol) were added in that order and stirring was continued overnight. Na<sub>2</sub>CO<sub>3</sub> (5%, 5 mL) was added and stirring was continued for an additional 30 min. The mixture was then extracted with EtOAc (3×) and the organic layer was washed with 5% Na<sub>2</sub>CO<sub>3</sub> (2×). The EtOAc layer was acidified with diluted HCl to pH 4, washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The resulting amorphous solid was dissolved in THF, cooled for 3 days at −20 °C, filtered to eliminate the residual DCU, and concentrated again to obtain crude <b>5e</b>. This material was dissolved in dry EtOAc (1 mL), 4 N HCl in dioxane (5 mL) was added, and the resulting mixture was stirred for 30 min. The solvents were distilled off and the residue was dried in vacuo to obtain crude <b>6e</b> (114 mg), which was used as such without further purification. </div><div class="NLM_p"><b><i>N</i></b><b>-[1-Acetyl-4-(piperazine-1-carbonyl)-piperidin-4-yl]-2,4-dichloro-3-(2,4-dimethyl-quinolin</b><b>-8-yloxymethyl)-benzenesulfonamide (6f).</b> A portion of 4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-piperidine-4-carboxylic acid hydrochloride salt (see preparation for <b>6e</b>; 60 mg, 0.098 mmol) was dissolved in dry DMF (1 mL). Acetic anhydride (9.3 μL, 0.098 mmol) and DIPEA (50 μL, 0.29 mmol) were added while stirring at room temperature. After 4 h (HPLC control), water (2 mL) was added and the solvents were distilled off in vacuo. Toluene was added, and the mixture was concentrated again (4×). The solid residue was triturated with Et<sub>2</sub>O to obtain crude <b>4f</b> (78 mg). This crude product (0.098 mmol) was dissolved in dry DMF (2 mL) and then EDAC (20.7 mg, 0.108 mmol), HOAt (14.7 mg, 0.108 mmol), DIPEA (32 μL, 0.098 mmol), and Boc-piperazine (20.1 mg, 0.108 mmol) were added in that order while stirring at room temperature. After 12 h (HPLC control), 5% NaHCO<sub>3</sub> (5 mL) was added and stirring was continued for an additional 30 min. Then EtOAc was added and the two phases were separated. The organic phase was washed with 5% NaHCO<sub>3</sub> (3×) and pH 4.2 buffer (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Flash chromatographic purification (silica, CHCl<sub>3</sub>, then CHCl<sub>3</sub>/MeOH 99:1, then CHCl<sub>3</sub>/MeOH 98:2) afforded pure <b>5f</b> (19 mg, 0.025 mmol). This was dissolved in dry dioxane (1 mL), and 4 N HCl in dioxane (2 mL) was added while cooling in an ice bath. At the end of the reaction (HPLC control), the solvents were distilled off and the residue was triturated with Et<sub>2</sub>O to obtain <b>6f</b> (18 mg, quantitative). MS <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>35</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S, 647,17; found, 648.1, 650.1 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-5-dimethylamino-pentanoic Acid (9).</b> BocOrn-OH (8) was suspended in MeOH (100 mL), and 37% aq HCHO (1.6 mL, 0.02 mmol) was added, followed by 10% Pd/C (200 mg). The reaction mixture was stirred under H<sub>2</sub> for 3 h, then the catalyst was filtered off, and the filtrate was concentrated to dryness. Et<sub>2</sub>O (100 mL) was added to the resulting oil, and stirring was continued to obtain a white solid, which was filtered off and washed with Et<sub>2</sub>O. A second precipitation was performed by dissolving the solid in the minimum amount of MeOH (3 mL) and then adding Et<sub>2</sub>O (100 mL). The desired product was finally collected by filtration, following a further wash with Et<sub>2</sub>O, as a highly hygroscopic white solid that was stored under nitrogen. Total yield, 1.60 g (60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 6.49 (1H, d), 6.05 (1H, d), 3.75−3.65 (1H, m), 2.70−2.53 (2H, m), 2.39 (6H, s), 1.70−1.41 (4H, m), 1.38 (9H, s). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 175.27, 155.94, 78.54, 58.21, 54.74, 43.99, 30.23, 29.09, 22.5. MS <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>, 260.0; found, 261.0 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-5-trimethylammonium-pentanoic Acid (10).</b> Amino acid <b>9</b> (1.16 g, 4.37 mmol) was dissolved <a name="jm005000300559" id="jm005000300559"></a> in MeOH (5 mL). <i>O</i>-Methyl-<i>N</i>,<i>N</i>‘-diisopropylisourea (0.87 mL, 4.81 mmol) was added, and the reaction mixture was stirred at room temprature for 18 h (MS-HPLC control). Solvent removal under reduced pressure, followed by addition of water (30 mL), caused the precipitation of the diisopropylurea, which was filtered off. The aqueous layer was washed with EtOAc (3 × 30 mL) to remove the unreacted <i>O</i>-methyl-<i>N</i>,<i>N</i>‘-diisopropylisourea, and then the water was again distilled off under reduced pressure. Absolute EtOH (3 × 50 mL) was added and then removed under reduced pressure until a white foam formed. Et<sub>2</sub>O (50 mL) was added, and the resulting suspension was stirred at room temperature for 1 h. Ammonium salt <b>10</b> was finally collected, after filtration and washing with Et<sub>2</sub>O, as a highly hygroscopic white solid that was stored under nitrogen (1.10 g, 90% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 6.49 (1H, d), 3.45 (1H, m), 3.29 (2H, m), 3.03 (9H, s), 1.75−1.58 (4H, m), 1.38 (9H, s). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 172.38, 155.73, 78.19, 66.3, 55.15, 52.6, 29.9, 28.06, 18.7. MS <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>, 275.0; found, 275.0 [M]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-(4-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-1-carboxy-butyl)-trimethyl-ammonium (12).</b> Amino acid <b>11</b> (0.100 g, 0.40 mmol) was dissolved in 10% NaOH (4 mL), Me<sub>2</sub>SO<sub>4</sub> (0.4 mL) was added, and the reaction mixture was stirred for 30 min at 0 °C and then for 30 min at room temperature (MS-HPLC control). The solution was neutralized with 0.5 N HCl, the solvent was removed under reduced pressure, and the residue was triturated with Et<sub>2</sub>O to obtain <b>12</b>, which was used without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>, 275.37; found, 275.4 [M]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-(1-Carboxy-butyl)-1,4-ditrimethyl-ammonium (14).</b> Amino acid <b>13</b> monochloride (0.200 g, 1.20 mmol) was dissolved in 10% NaOH (5 mL), Me<sub>2</sub>SO<sub>4</sub> (0.5 mL) was added, and the reaction mixture was stirred for 30 min at 0 °C and for 30 min at room temperature (MS-HPLC control). The solution was neutralized with 0.5 N HCl, the solvent was removed under reduced pressure, and the residue was triturated with Et<sub>2</sub>O to obtain <b>14</b>, which was used without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, 218.34; found, 218.5 [M]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-6-Amino-3-</b><b><i>tert</i></b><b>-butoxycarbonylamino-hexanoic Acid (16).</b> A solution of Boc-β-Lys(<i>Z</i>)-OH (210 mg, 0.55 mmol) in MeOH (20 mL) was stirred under H<sub>2</sub> in the presence of 10% Pd/C (50 mg). At the end of the reaction (TLC control, silica, CHCl<sub>3</sub>/MeOH 9:1), the solution was filtered through Celite and the filtrate was concentrated in vacuo to obtain <b>16</b> (130 mg, 96%) as a colorless oil. MS <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, 218.34; found, 219.2 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-6-[(</b><b><i>tert</i></b><b>-Butoxycarbonimidoylimino-</b><b><i>tert</i></b><b>-butoxycarbonylamino-methyl)-amino]-3-</b><b><i>tert</i></b><b>-bu</b><b>toxycarbonylamino Hexanoic Acid (17).</b> A suspension of <b>16</b> (130 mg, 0.52 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated with BSA (0.40 mL, 1.56 mmol) until complete solution occurred. Goodman's reagent (600 mg, 1.56 mmol) was added, and stirring was continued at room temperature for 24 h. At the end of the reaction (TLC control, silica, CHCl<sub>3</sub>/MeOH 9:1), the mixture was concentrated under reduced pressure, and the crude residue was purified by flash chromatography (silica, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 9:1) to obtain <b>17</b> (112 mg, 44%). MS <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>40</sub>N<sub>4</sub>O<sub>8</sub>, 488.594; found, 489.6 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-3-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-6-dimethylamino-hexanoic Acid (18).</b> A solution of <b>16</b> (113 mg, 0.45 mmol) in dioxane (10 mL) was treated with 37% aq HCHO (250 μL, 3.0 mmol), and NaCNBH<sub>3</sub> (75 mg, 1.2 mmol) in water (3 mL) was added. At the end of the reaction (TLC control, silica, AcCN/water 5:15), the mixture was concentrated under reduced pressure, and the crude product was purified by flash chromatography (silica, CH<sub>3</sub>CN/H<sub>2</sub>O 1:4) to obtain <b>18</b> (65 mg, 55%). MS <i>m</i>/<i>z</i> calcd for C<sub>131</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>, 274.36; found, 275.4 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>4-[(</b><b><i>S</i></b><b>)-3-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-6-dimethylamino-hexanoyl]-piperazine-1-carboxylic </b><b>Acid 9</b><b><i>H</i></b><b>-Fluoren-9-ylmethyl Ester (19).</b> Pd/C (10%, 45 mg) was wetted with three drops of water, suspended in AcOH (2 mL), and added, under nitrogen, to a solution of <b>22</b> (400 mg, 0.596 mmol) in AcOH (4 mL). The resulting mixture was cooled in a water bath to 10 °C and degassed with nitrogen for 10 min. Hydrogen was then bubbled through the mixture while the temperature was maintained below 15 °C by periodic addition of solid CO<sub>2</sub> to the water bath. At the end of the deprotection reaction (HPLC control), the solution was degassed with nitrogen for 20 min, while maintaining the temperature at 0 °C, and then filtered. The filtrate was concentrated in vacuo to give the free amine as the acetate salt. This crude product was purified by flash chromatography (CHCl<sub>3</sub>/MeOH/AcOH 85:10:5) to obtain the pure amine as the acetate salt. MS <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>40</sub>N<sub>4</sub>O<sub>5</sub>, 536.30; found, 537.3 [M + H]<sup>+</sup>. HPLC purity:  system B, >99%, <i>t</i><sub>R</sub> 16.42 min. </div><div class="NLM_p">This salt was dissolved in CH<sub>2</sub>Cl<sub>2</sub>/AcOH 9:1 (10 mL), and 37% aq HCHO (220 μL, 2.71 mmol) was added. The resulting solution was agitated (150 oscillations/min) at room temperature for 20 min, (polystyrylmethyl)trimethylammonium cyanoborohydride (339 mg, 1.39 mmol) was added, and the agitation was continued at room temperature. At the end of the reaction (HPLC and TLC control), the resin was filtered off under nitrogen and washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL), and the filtrates were combined and concentrated in vacuo to give <b>19</b> (318 mg) as an off-white solid after concentration from toluene (3×). A portion of this product was used in the next step without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>44</sub>N<sub>4</sub>O<sub>5</sub>, 564.33; found, 565.3 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>{(</b><b><i>S</i></b><b>)-4-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-6-[4-(9</b><b><i>H</i></b><b>-fluoren-9-ylmethoxycarbonyl)-piperazin-1-yl]-6-</b><b>oxo-hexyl}-trimethyl-ammonium trifluoroacetate (20).</b> Methyl iodide (160 μL, 2.57 mmol) was added to a solution of <b>19</b> (260 mg, 0.419 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/MeOH (2:1; 6 mL) and stirring at room temperature was continued for 2 days. At the end of the reaction (HPLC control), the solvents were removed in vacuo and the residue was triturated with Et<sub>2</sub>O. The resulting off-white solid was filtered under nitrogen, washed with Et<sub>2</sub>O (3 × 6 mL), and dried under a stream of nitrogen to give crude <b>20</b>. This crude product was purified by preparative HPLC to obtain pure <b>20</b> (118 mg, 40%) as the trifluoroacetate salt. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>):  δ 7.78−7.74 (2H, m), 7.60−7.53 (2H, m), 7.42−7.37 (2H, m), 7.37−7.28 (2H, m), 5.88−5.71 (1H, br s), 4.49 (2H, d, <i>J</i> = 6.4 Hz), 4.29−4.20 (1H, t, <i>J</i> = 6.4 Hz), 4.02−3.86 (1H, br s), 3.64−3.29 (10H, m), 3.16 (9H, m), 2.70−2.47 (2H, m), 1.99−1.69 (3H, m), 1.68−1.49 (1H, m), 1.41 (9H, s). MS <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>47</sub>N<sub>4</sub>O<sub>5</sub>, 579.35; found, 579.2 [M + H]<sup>+</sup>. HPLC purity:  system B, 98.6%, <i>t</i><sub>R</sub> 16.90 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-6-oxo-6-piperazin-1-yl-hexyl]-trimethyl-ammonium </b><b>Trifluoroacetate (21).</b> A solution of <b>20</b> (84 mg, 0.119 mmol) in 20% piperidine/DMF (2.4 mL) was stirred at room temperature. At the end of the deprotection reaction (HPLC control), the solvents were removed in vacuo and the residue was concentrated twice from DMF under reduced pressure. The resulting white solid was triturated with Et<sub>2</sub>O and the supernatant was removed by pipet. The residue was dissolved in MeOH and concentrated again to obtain <b>21</b> in the form of the trifluoroacetate salt (59 mg), which was used as such without any further purification. </div><div class="NLM_p"><b>4-[(</b><b><i>S</i></b><b>)-6-Benzyloxycarbonylamino-3-</b><b><i>tert</i></b><b>-butoxycarbonylamino-hexanoyl]-piperazine-1-car</b><b>boxylic Acid 9</b><b><i>H</i></b><b>-Fluoren-9-ylmethyl Ester (22).</b> Commercially available Boc-β-Lys(<i>Z</i>)-OH DCHA (987 mg, 1.76 mmol) was partitioned between EtOAc (100 mL) and 1 N HCl (100 mL). The layers were separated, and the organic phase was washed with water (2 × 50 mL) and brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give <b>15</b> as the free acid. A solution of acid <b>15</b> (447 mg, 1.17 mmol), HOBt (217 mg, 1.42 mmol), and EDAC (286 mg, 1.49 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was stirred at 0 °C for 30 min. Then Fmoc-piperazine hydrochloride (412 mg, 1.19 mmol) was added, followed by DIPEA (420 μL, 2.41 mmol), and stirring was continued at 0 °C for 30 min and then at room temperature. At the end of the reaction (HPLC control), the solvent was distilled off in vacuo, and the residue was partitioned between EtOAc (50 mL) and 1 N HCl (50 mL). The layers were separated and the organic phase was washed with 1 N HCl (50 mL). The combined acid washes were back-extracted with EtOAc (50 mL), then the organic extracts were combined and washed with 5% NaHCO<sub>3</sub> (2 × 50 mL), water (50 mL), and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to afford crude <b>22</b> (694 mg, 88%) as a pale yellow foam. <sup>1</sup>H NMR (300 <a name="jm005000300560" id="jm005000300560"></a> MHz, DMSO-<i>d</i><sub>6</sub>):  δ 7.94−7.80 (2H, m), 7.68−7.60 (2H, m), 7.46−7.29 (9H, m), 7.26−7.19 (1H, br t, <i>J</i> = 5.5 Hz), 6.70−6.63 (1H, d, <i>J</i> = 8.8 Hz), 4.99 (2H, s), 4.46−4.37 (2H, d, <i>J</i> = 6.1 Hz), 4.33−4.25 (1H, t, <i>J</i> = 6.2 Hz), 3.77−3.65 (1H, m), 3.45−3.25 (8H, m), 3.02−2.91 (2H, m), 2.48−2.28 (2H, m), 1.48−1.28 (13H, m). HPLC purity:  system B, 83.6%, <i>t</i><sub>R</sub> 23.26 min. </div><div class="NLM_p"><b>4-[(</b><b><i>S</i></b><b>)-3-Amino-6-benzyloxycarbonylamino-hexanoyl]-piper-azine-1-carboxylic Acid </b><b>9</b><b><i>H</i></b><b>-Fluoren-9-ylmethyl Ester (23).</b> A 4 N solution of HCl in dioxane (4 mL, 8 mmol) was added dropwise to a solution of <b>22</b> (232 mg, 0.346 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL), and stirring was continued for 40 min at room temperature. The solvents were removed in vacuo<i>,</i> and the residue was dissolved in MeOH, concentrated (2×), dissolved in toluene/MeOH (1:1), and concentrated again. The resulting oil was triturated with Et<sub>2</sub>O to obtain a solid, which was filtered off under nitrogen to give <b>23</b> (198 mg, 94%) as the hydrochloride salt. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 7.92−7.87 (2H, m), 7.82−7.71 (3H, br s), 7.65−7.60 (2H, m), 7.46−7.24 (10H, m), 5.01 (2H, s), 4.45−4.38 (2H, d, <i>J</i> = 6.2 Hz), 4.31−4.25 (1H, t, <i>J</i> = 6.2 Hz), 3.50−3.31 (8H, m), 3.04−2.94 (2H, m), 2.77−2.68 (1H, m), 2.60−2.52 (1H, m), 1.64−1.42 (4H, m). HPLC purity:  system B, 90.3%, <i>t</i><sub>R</sub> 17.72 min. </div><div class="NLM_p"><b>4-[(</b><b><i>S</i></b><b>)-6-Benzyloxycarbonylamino-3-dimethylamino-hexanoyl]-piperazine-1-carboxylic </b><b>Acid 9</b><b><i>H</i></b><b>-Fluoren-9-ylmethyl Ester (24).</b> A solution of <b>23</b> (82 mg, 0.135 mmol) and 37% aq HCHO (66 μL, 0.81 mmol) in MeOH (2 mL) was stirred at room temperature for 20 min. (Polystyryl)trimethylammonium cyanoborohydride (124 mg, 4.1 mmol) was added and stirring was continued at room temperature. At the end of the reaction (HPLC control), the resin was filtered off and washed with MeOH (3×), and the filtrates were combined and concentrated under reduced pressure to give crude <b>24</b> (83 mg, 97%) as a colorless oil, which was used, as such, without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>42</sub>N<sub>4</sub>O<sub>5</sub>, 598.32; found, 599.1 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>((</b><b><i>S</i></b><b>)-4-Benzyloxycarbonylamino-1-{2-[4-(9</b><b><i>H</i></b><b>-fluoren-9-ylmethoxycarbonyl)-piperazin-1-yl]-</b><b>2-oxo-ethyl}-butyl)-trimethyl-ammonium (25).</b> A solution of crude <b>24</b> (77 mg, 0.12 mmol) and MeI (80 μL, 1.3 mmol) in MeOH (2 mL) was stirred at room temperature for five days. Because some starting amine still remained, the solvents were distilled off in vacuo, and the residue was dissolved in neat MeI (4 mL) and stirred at room temperature in the dark for an additional three days. The MeI was removed in vacuo, and the residue was purified by preparative HPLC to obtain <b>25</b> (54 mg, 62%), as a colorless oil, in the form of trifluoroacetate salt. MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>45</sub>N<sub>4</sub>O<sub>5</sub>, 613.34; found, 613.20 [M]<sup>+</sup>. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Benzyloxycarbonylamino-1-(2-oxo-2-piperazin-1-yl-ethyl)-butyl]-trimethyl-ammoniu</b><b>m Iodide (26).</b> A solution of <b>25</b> (54 mg, 0.074 mmol) in 20% piperidine/DMF (4 mL) was stirred at room temperature for 30 min, then the solvents were removed under reduced pressure, and the residue was concentrated from DMF (2×). The resulting white crystalline solid was triturated with Et<sub>2</sub>O (4 mL × 3) to remove the benzofulvene-piperidine adduct, and the residue was dried in vacuo to obtain <b>26</b> (39 mg, quantitative) as a white solid, which was used as such. MS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub>, 391.27; found, 391.3 [M]<sup>+</sup>. </div><div class="NLM_p"><b>[(</b><b><i>R</i></b><b>)-5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-1-carboxy-pentyl]-trimethyl-ammonium (29).</b> A solution of <b>27</b> (150 mg, 0.38 mmol) in MeOH (10 mL) was stirred under H<sub>2</sub> in the presence of 10% Pd/C (100 mg). When the deprotection reaction was complete, the mixture was filtered through Celite and the solution was concentrated in vacuo. The crude product was dissolved in 10% NaOH (4 mL), Me<sub>2</sub>SO<sub>4</sub> (0.4 mL) was added, and stirring was continued in an ice bath for 30 min and then at room temperature for an additional 30 min. The reaction was neutralized by the dropwise addition of 5 N HCl, and the solution was concentrated in vacuo to obtain crude <b>29</b>, which was used as such without any further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>30</sub>N<sub>2</sub>O<sub>4</sub>, 290.41; found, 290.5 [M ]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2,6-Bis-dimethylamino-hexanoic Acid (31).</b> A solution of<b> 30</b> (300 mg, 1.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and TFA (1 mL) was stirred at room temperature for 2 h. At the end of the reaction (TLC control), the solvents were distilled off in vacuo to obtain crude <b>31</b>. This was dissolved in dioxane (5 mL), and 37% aq HCHO (0.67 mL) was added, followed by a solution of NaCNBH<sub>3</sub> (164 mg, 2.6 mmol) in water. At the end of the reaction (TLC control, RP-18, AcCN/water 1:1), the solvents were distilled off under reduced pressure and the residue was purified by RP-flash chromatography to obtain <b>31</b> (127 mg, 60%). MS <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>, 202.30; found, 203.4 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2,6-Bis-trimethylammonium-hexanoic Acid (32).</b> A mixture of <b>31</b> (70 mg, 0.3 mmol) in MeOH (3 mL), NaOH (70 mg, 1.75 mmol) in water (1.5 mL), and Me<sub>2</sub>SO<sub>4</sub> (0.5 mL, 0.45 mmol) was stirred for 30 min in an ice bath and then for 30 min at room temperature. It was neutralized by the dropwise addition of 1 N HCl, and the solvents were distilled off in vacuo. The residue was washed with petroleum ether to leave the ammonium salts <b>32</b> as a mixture with NaCl, which was used, as such, without further purification. MS <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>, 232.2; found, 231.4 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b>General Synthesis of the </b>ω<b> Ammonium Salts 34 (Scheme 6).</b> A solution of the commercially available Boc-protected derivatives <b>33</b> (0.43 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and TFA (1 mL) was stirred at room temperature for 1 h. The solvents were distilled off in vacuo, and the residue was dissolved in 10% NaOH (4 mL) and Me<sub>2</sub>SO<sub>4</sub> (0.4 mL) was added. After 30 min, the mixture was neutralized by the dropwise addition of 1 N HCl. The solvents were distilled off in vacuo, and the residue was washed with petroleum ether to leave the ammonium salts <b>34</b> as a mixture with NaCl, which were used, as such, without further purification. </div><div class="NLM_p"><b>4-{</b><b><i>tert</i></b><b>-Butoxycarbonylamino-[(</b><b><i>E</i></b><b>)-</b><b><i>tert</i></b><b>-butoxycarbonylimino]-methyl}-piperazine-1-carbox</b><b>ylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (36).</b> A solution of <i>tert</i>-butyl 1-piperazinecarboxylate (252 mg, 1.35 mmol), DIPEA (290 μL, 1.66 mmol), and Goodman's reagent (446 mg, 1.14 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was stirred at room temperature overnight. At the end of the reaction (HPLC control), the solvent was removed in vacuo and the residue was partitioned between ethyl acetate (50 mL) and ice cooled 1 N HCl (50 mL). The layers were separated and the organic phase was washed with 1 N HCl (50 mL). The acid washes were combined and back-extracted with EtOAc (50 mL). The organic extracts were combined and washed with 5% NaHCO<sub>3</sub> (2 × 50 mL) and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to obtain <b>36</b> (335 mg, 69%) as a colorless oil, which was used, as such, in the next reactions. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.95 (1H, br s), 3.34 (8H, br s), 1.45−1.34 (27H, m). HPLC purity:  system B, 93.3%, <i>t</i><sub>R</sub> 16.39 min. </div><div class="NLM_p"><b>4-{[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(3-dimethylamino-propyl)-amino]-[(</b><b><i>Z</i></b><b>)-</b><b><i>tert</i></b><b>-butoxycarbonylimino]-</b><b>methyl}-piperazine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (37).</b> DIAD (272 μL, 1.38 mmol) was added dropwise (at such a rate that the yellow coloration disappeared between each addition) to an ice-cold solution of <b>36</b> (198 mg, 0.462 mmol), triphenylphosphine (606 mg, 2.31 mmol), and 3-dimethylaminopropanol (163 μL, 1.38 mmol) in anhydrous THF (3 mL). When the addition was complete, the cooling bath was removed and the reaction was stirred at room temperature for 18 h. The solvent was removed in vacuo, and the residue was purified by flash chromatography, eluting with chloroform−MeOH (9:1), to give <b>37</b> (180 mg, 76%). MS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>47</sub>N<sub>5</sub>O<sub>6</sub>, 513.35; found, 514.2 [M + H]<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Dimethylamino-propyl)-piperazine-1-carboxamidine (38).</b> A solution of 4 N HCl in dioxane (3 mL) was added to <b>37</b> (60 mg, 0.117 mmol) in MeOH (1 mL), and the reaction was stirred at room temperature overnight. The solvents were distilled off under reduced pressure to give <b>38</b> (40 mg, quantitative yield) as the hydrochloride salt, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 10.79 (1H, br s), 9.59 (2H, br s), 8.48 (1H, br s), 8.12 (2H, br s), 3.80−3.40 (8H, m), 3.38−3.29 (2H, m), 3.15−3.05 (2H, m), 2.75 (6H, s), 2.05−1.87 (2H, m). </div><div class="NLM_p"><b>[3-(</b><b><i>tert</i></b><b>-Butoxycarbonyl-{[(</b><b><i>E</i></b><b>)-</b><b><i>tert</i></b><b>-butoxycarbonylimino]-piperazin-1-yl-methyl}-amino)-pr</b><b>opyl]-trimethyl-ammonium (39).</b> A solution of <b>37</b> (50 mg, 0.097 mmol) and MeI (60 μL, 0.58 mmol) in Et<sub>2</sub>O was stirred overnight at room temperature. A white precipitate formed, which was filtered off and dried in vacuo to <a name="jm005000300561" id="jm005000300561"></a> give crude <b>39</b> (50 mg, 70%), which was used, as such, in the next reaction. MS <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>21</sub>N<sub>5</sub>, 199.30; found, 528.2 [M]<sup>+</sup>. </div><div class="NLM_p"><b>Trimethyl-{3-[(piperazine-1-carboximidoyl)-amino]-propyl}-ammonium (40).</b> A solution of 4 N HCl in dioxane (3 mL) was added to crude <b>39</b> (50 mg, 0.099 mmol) in MeOH (1 mL), and the reaction was stirred at room temperature overnight. The solvents were removed in vacuo, and the residue was triturated with Et<sub>2</sub>O to give crude <b>40</b> as a highly hygroscopic solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.65 (2H, br s), 8.59 (1H, br s), 8.15 (2H, br s), 3.85−3.75 (4H, m), 3.43−3.38 (4H, m), 3.36−3.28 (4H, m), 3.11 (9H, s), 2.08−1.96 (2H, m). </div><div class="NLM_p"><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-2-Amino-6-dimethylamino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-2,4-</b><b>dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt </b><b>(44).</b> A solution of the Boc-Lys(Me)<sub>2</sub>OH (13 mg, 0.046 mmol) in DMF (5 mL) was cooled in an ice bath. EDAC (9.0 mg, 0.046 mmol) and HOAt (6.3 mg, 0.046 mmol) were added and stirring was continued for 1 h. Amine <b>6a</b> (25 mg, 0.031 mmol) and DIPEA (8 μL, 0.046 mmol) were added and stirring was continued at room temperature overnight. At the end of the reaction (HPLC control), the solvent was distilled off in vacuo, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and TFA (1 mL) was added. At the end of the Boc-deprotection reaction (HPLC control), the solvents were distilled off again and the crude residue was purified by preparative HPLC to obtain <b>44</b> (30 mg, 88%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.44 (1H, br s), 8.64 (1H, s), 8.23−8.10 (3H, br s), 8.03 (1H, d), 7.83 (1H, d), 7.75 (1H, br s), 7.69−7.33 (8H, m), 5.59 (2H, s), 4.48 (1H, br s), 3.00 (1H, m), 2.78 (6H, s), 2.74−2.58 (4H, m), 2.60 (6H, s), 2.06−1.23 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>48</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 746.28; found, 747.2 [M + H]<sup>+</sup>. HPLC purity:  System B, 98.7%, <i>t</i><sub>R</sub> = 8.96 min. </div><div class="NLM_p"><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-3-Amino-6-dimethylamino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-2,4-</b><b>dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt </b><b>(45).</b> A solution of acid <b>18</b> (9.0 mg, 0.032 mmol) in DMF (3 mL) was cooled in an ice bath. EDAC (6.0 mg, 0.032 mmol) and HOAt (4.0 mg, 0.032 mmol) were added, and the resulting mixture was stirred for an additional hour at 0 °C. Then amine <b>6a</b> (15 mg, 0.022 mmol) and DIPEA (5 μL, 0.032 mmol) were added and stirring was continued for 12 h at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3.0 mL), and TFA (0.7 mL) was added. At the end of the Boc-deprotection reaction (HPLC control), the solvents were distilled off again and the residue was purified by preparative HPLC to obtain <b>45</b> (15 mg, 63% yield) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.47 (1H, br s), 8.61 (1H, s), 8.03 (1H, d), 7.82 (1H, d), 7.81 (3H, s), 7.68 (1H, d), 7.51 (1H, t), 7.39 (1H, d), 7.32 (1H, br s), 5.55 (2H, s), 3.52 (8H, m), 3.03−2.84 (2H, br s), 2.76 (3H, s), 2.63 (3H, s), 2.56 (3H, s), 2.03−1.34 (10H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>48</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 746.28; found, 747.3 [M + H]<sup>+</sup>. HPLC purity:  System B, 95%, <i>t</i><sub>R</sub> = 8.85 min. </div><div class="NLM_p"><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-2-Amino-6-guanidino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-2,4-dichl</b><b>oro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt (46).</b> A solution of Boc-<span class="smallcaps smallerCapital">l</span>-homoarginine hydrochloride (17 mg, 0.046 mmol) in DMF (3.0 mL) was cooled in an ice bath. EDAC (9.0 mg, 0.046 mmol) and HOAt (6.3 mg, 0.046 mmol) were added, and the resulting mixture was stirred for an additional hour at 0 °C. Then amine <b>6a</b> (25 mg, 0.031 mmol) and DIPEA (8 μL, 0.046 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3.0 mL), and TFA (1.0 mL) was added. At the end of the Boc-deprotection reaction (HPLC control), the solvents were distilled off again and the residue was purified by preparative HPLC to afford <b>46</b> (27 mg, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.65 (1H, s), 8.14 (3H, br s), 8.04 (1H, d), 7.83 (1H, d), 7.81−7.44 (5H, m), 7.39−6.76 (3H, s), 5.50 (2H, s), 4.46 (1H, br s), 3.07 (2H, m), 2.72 (3H, s), 2.67 (3H, s), 2.03−1.91 (2H, m), 1.80−1.61 (4H, m), 1.53−1.25 (10H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>5</sub>S, 760.27; found, 761.1 [M + H]<sup>+</sup>. HPLC purity:  System B, 95%, <i>t</i><sub>R</sub> = 8.80 min. </div><div class="NLM_p"><b>2,4-Dichloro-</b><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-2,6-diamino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-3-(2,4</b><b>-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt (47).</b> A solution of Boc-<span class="smallcaps smallerCapital">d</span>-Lys(Boc)-OH (20 mg, 0.060 mmol) in DMF (3.0 mL) was cooled in an ice bath. EDAC (11.0 mg, 0.060 mmol) and HOAt (8.0 mg, 0.060 mmol) were added, and the resulting mixture was stirred for an additional hour at 0 °C. Amine <b>6a</b> (30 mg, 0.040 mmol) and DIPEA (9.0 μL, 0.05 mmol) were added, and stirring was continued at room temperature overnight. At the end of the reaction, the solvents were distilled off in vacuo, the residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL), and TFA (0.5 mL) added. At the end of the Boc-deprotection reaction, solvents were distilled off in vacuo, and the residue was purified by preparative HPLC to obtain <b>47</b> (42 mg, 96%) in the form of trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.32 (1H, s), 8.10 (3H, br s), 8.02 (1H, d), 7.80 (3H, br s), 7.77 (1H, d), 7.76−7.33 (2H, m), 7.45 (1H, t), 7.30 (2H, m), 5.68 (2H, s), 4.48 (1H, br s), 2.81 (2H, br s), 2.79 (3H, s), 2.68 (3H, s), 2.02 (2H, s), 1.80 (4H, br s), 1.45−1.60 (8H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 718.25; found, 719.2 [M + H]<sup>+</sup>. HPLC purity:  System B, 98%, <i>t</i><sub>R</sub> = 8.51 min. </div><div class="NLM_p"><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-2,6-Bis-dimethylamino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-2,4-dich</b><b>loro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt </b><b>(48).</b> A solution of (<i>S</i>)-2,6-bis-dimethylaminohexanoic acid (20 mg, 0.096 mmol), EDAC (28 mg, 0.096 mmol), and HOAt (20 mg, 0.096 mmol) in DMF (5.0 mL) was cooled in an ice bath. After 1 h, amine <b>6a</b> (50 mg, 0.072 mmol) and DIPEA (11 μL, 0.072 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the crude product was purified by preparative HPLC to obtain <b>48</b> (50.5 mg, 63%) as a trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.40 (1H, br s), 8.32 (1H, s), 8.02 (1H, d), 7.77 (1H, d), 7.76−7.33 (4H, m), 5.68 (2H, s), 4.48 (1H, br s), 3.89−3.45 (8H, m), 3.18−3.04 (2H, m), 2.81 (3H, s), 2.79 (3H, s), 2.68 (3H, s), 2.64 (3H, s), 2.09−1.28 (10H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>52</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 774.31; found, 775.3 [M + H]<sup>+</sup>. HPLC purity:  System B, >99%, <i>t</i><sub>R</sub> = 8.65 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-5-Amino-6-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazin-1-yl)-6-oxo-hexyl]-trimethyl-ammonium </b><b>Trifluoro-acetate Salt (49).</b> A solution of (<i>S</i>)-2-Fmoc-amino-6-trimethylammoniumhexanoic acid (20 mg, 0.045 mmol), EDAC (13 mg, 0.067 mmol), and HOAt (9 mg, 0.067 mmol) in DMF (5.0 mL) was cooled in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.045 mmol) and DIPEA (7 μL, 0.045 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) and piperidine (1 mL). At the end of the Fmoc-deprotection reaction, the crude product was purified by preparative HPLC to obtain <b>49</b> (15 mg, 29%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.66 (1H, s), 8.27−8.12 (3H, br s), 8.04 (1H, d), 7.84 (1H, d), 7.81−7.37 (4H, m), 5.60 (2H, s), 4.60−4.42 (1H, br s), 3.70−3.42 (8H, m), 3.24 (2H, m), 3.15 (9H, s), 2.75 (3H, s), 2.67 (3H, s), 2.04−1.93 (2H, m), 1.82−1.22 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>51</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 761.3; found, 761.4 [M]<sup>+</sup>. HPLC purity:  System B, 98.8%, <i>t</i><sub>R</sub> = 8.61 min. </div><div class="NLM_p"><b>2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-</b><b><i>N</i></b><b>-{1-[4-(6-guanidino-hexanoyl)-pipe</b><b>razine-1-carbonyl]-cyclopentyl}-benzenesulfonamide Trifluoroacetate Salt (50).</b> A solution of 6-Boc-amino-hexanoic acid (7.4 mg, 0.032 mmol) in DMF (2.0 mL) was cooled in an ice bath. EDAC (6.0 mg, 0.032 mmol) and HOAt (4.3 mg, 0.032 mmol) were added, and the resulting mixture was stirred for an additional hour at 0 °C. Amine <b>6a</b> (15 mg, 0.022 mmol) and DIPEA (5.0 μL, 0.032 mmol) were added and stirring was continued at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was treated with CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and TFA (0.5 mL). At the <a name="jm005000300562" id="jm005000300562"></a> end of the Boc-deprotection reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was purified by preparative HPLC. The resulting amine was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, Goodman's reagent (15 mg, 0.037 mmol) and DIPEA (7 mg, 0.055 mmol) were added, and the resulting mixture was stirred at room temperature overnight. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was purified by preparative HPLC to obtain <b>50</b> (10 mg, 47%) as trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.44 (1H, s), 8.02 (1H, d), 7.79 (1H, d), 7.76−7.32 (5H, m), 7.05−6.84 (4H, br s), 5.55 (2H, s), 3.66−3.47 (8H, m), 3.10 (2H, m), 2.68 (3H, s), 2.52 (3H, s), 2.38−2.32 (2H, m), 2.08−1.23 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>45</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>5</sub>S, 745.26; found, 746.5 [M + H]<sup>+</sup>. HPLC purity:  System B, 96.5%, <i>t</i><sub>R</sub> = 10.17 min. </div><div class="NLM_p"><b>[6-(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cycl</b><b>opentanecarbonyl}-piperazin-1-yl)-6-oxo-hexyl]-trimethyl-ammonium Trifluoroacetate Salt </b><b>(51).</b> A solution of (5-carboxy-pentyl)-trimethyl-ammonium (80 mg, 0.17 mmol), EDAC (32 mg, 0.17 mmol), and HOAt (23 mg, 0.17 mmol) in DMF (5 mL) was cooled in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.04 mmol) and DIPEA (6 μL, 0.04 mmol) were added, and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was purified by preparative HPLC to give <b>51</b> (24 mg, 61%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.30 (1H, s), 8.07 (1H, d), 8.02−7.94 (1H, m), 7.91−7.76 (4H, m), 5.74 (2H, s), 3.67−3.50 (8H, m), 3.34−3.26 (2H, m), 3.07 (9H, s), 2.92 (3H, s), 2.68 (3H, s), 2.91 (3H, s), 2.43−2.36 (2H, m), 2.12−1.33 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>50</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S, 746.29; found, 746.2 [M]<sup>+</sup>. HPLC purity:  System B, 99%, <i>t</i><sub>R</sub> = 9.99 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-1-(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-</b><b>cyclopentanecarbonyl}-piperazine-1-carbonyl)-5-guanidino-pentyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (52).</b> A solution of <b>54</b> (6.0 mg, 0.005 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) was treated with Goodman's reagent (8.0 mg, 0.02 mmol) and DIPEA (0.04 mmol) and stirred at room temperature for 1 h. At the end of the reaction (HPLC control), TFA was added (0.5 mL) and stirring was continued until deprotection of Boc groups was complete (HPLC control). The solvents were distilled off, and the residue was purified by preparative HPLC to obtain <b>52</b> (5.0 mg, 87%) as trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.39 (1H, s), 8.02 (1H, d), 7.78 (1H, d), 7.76 (1H, d), 7.58 (1H, m), 7.35−7.30 (3H, m), 6.95 (4H, br s), 5.65 (2H, s), 4.61 (1H, d), 3.85−3.62 (10H, m), 3.05 (9H, s), 2.72 (3H, s), 2.68 (3H, s), 1.80−1.69 (3H, m), 1.60−1.53 (7H, m), 1.48−1.40 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>53</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>5</sub>S, 803.32; found, 803.3 [M + H]<sup>+</sup>. HPLC purity:  System B, 97%, <i>t</i><sub>R</sub> = 7.84 min. </div><div class="NLM_p"><b><i>N</i></b><b>-[1-[4-(2-(</b><b><i>S</i></b><b>)-trimethylammonium-6-trimethylammonium-hexanoyl)-piperazin-1-yl]-cyclo</b><b>pentyl]-2,4-dichloro-3-(2,4-di-methyl-quinolin-8-yloxymethyl)-benzenesulfonamide </b><b>Trifluoroacetate Salt (53).</b> A solution of acid <b>36</b> (10 mg, 0.04 mmol), EDAC (5.0 mg, 0.04 mmol), and HOAt (8.0 mg, 0.04 mmol) in DMF (5.0 mL) was cooled in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.046 mmol) and DIPEA (7 μL, 0.046 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off and the crude residue was purified by preparative HPLC to obtain <b>53</b> (20.5 mg, 39%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.32 (1H, s), 8.02 (1H, d), 7.78 (1H, d), 7.73 (1H, d), 7.59−7.31 (3H, m), 5.68 (2H, s), 4.68−4,60 (1H, m), 4.01−3.56 (8H, m), 3.36−3.28 (2H, m), 3.22 (9H, s), 3.08 (9H, s), 2.68 (3H, s), 2.63 (3H, s), 2.13−1.43 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>58</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 804.3; found, 803.3 [M − H]<sup>+</sup>. HPLC purity:  System B, 99.6%, <i>t</i><sub>R</sub> = 8.80 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-5-Amino-1-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazine-1-carbonyl)-pentyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (54).</b> A solution of crude (<i>S</i>)-(5-<i>tert</i>-butoxycarbonylamino-1-carboxy-pentyl)-trimethyl-ammonium (50 mg, 0.17 mmol), EDAC (32 mg, 0.17 mmol), and HOAt (23 mg, 0.17 mmol) in DMF (5 mL) was cooled in an ice bath. After 1 h, amine <b>6a</b> (50 mg, 0.11 mmol) and DIPEA (25 μL, 0.11 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>/TFA (3:1; 5.0 mL). After deprotection of the Boc group, the solvents were distilled off and the crude product was purified by preparative HPLC to afford <b>54</b> (21 mg, 17%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.35 (1H, s), 8.07 (1H, d), 8.01−7.94 (1H, m), 7.87 (2H, s), 7.80 (1H, d), 7.77−7.59 (3H, br s), 5.74 (2H, s), 4.65−4.58 (1H, m), 3.98−3.51 (8H, m), 3.22 (9H, s), 2.91 (6H, s), 2.82−2.80 (2H, m), 2.13−1.41 (14H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>51</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 761.3; found, 761.4 [M]<sup>+</sup>. HPLC purity:  System B, 99.2%, <i>t</i><sub>R</sub> = 8.64 min. </div><div class="NLM_p"><b>2,4-Dichloro-</b><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-3,6-diamino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-3-(2,4</b><b>-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt (55).</b> A solution of β-Boc-lysine (22 mg, 0.064 mmol), HOAt (87 mg, 0.043 mmol), and EDAC (12.2 mg, 0.043 mmol) in DMF (3.0 mL) was stirred at room temperature for 1 h. Then a solution of <b>6a</b> (30 mg, 0.043 mmol) and DIPEA (10 μL, 0.043 mmol) in DMF (2.0 mL) was added and stirring was continued at room temperature overnight. At the end of the reaction (HPLC control), the solvent was distilled off and the residue was dissolved in TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1; 3.0 mL). At the end of the reaction (HPLC control), the solvents were distilled off and the crude product was purified by preparative HPLC to obtain <b>55</b> (28 mg, 61%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.62 (1H, s), 8.04 (1H, d), 7.90−7.32 (12H, m), 5.59 (2H, s), 3.58−3.41 (8H, m), 2.86−2.56 (9H, m), 2.03−1.21 (12H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 718.25.72; found, 719.4 [M + H]<sup>+</sup>. HPLC purity:  System B, 99%, <i>t</i><sub>R</sub> = 8.79 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-6-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazin-1-yl)-6-oxo-hexyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (56).</b> A solution of acid <b>4a</b> (65 mg, 0.124 mmol), HOAt (22 mg, 0.16 mmol), and EDAC (32 mg, 0.17 mmol) in DMF (2 mL) was stirred in an ice bath for 30 min, then a solution of <b>21</b> (58 mg, 0.12 mmol) in DMF (2 mL) was added, followed by dropwise addition of DIPEA (42 μL, 0.24 mmol). Stirring was continued at 0 °C for 30 min, then at room temperature overnight. At the end of the reaction (HPLC control) the solvents were removed in vacuo. The residue was dissolved in CH<sub>3</sub>CN/water (1:1) and purified by preparative HPLC to obtain the Boc-protected intermediate as trifluoroacetate salt. This compound was dissolved in TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1; 4 mL) and stirred at room temperature overnight. The solvents were distilled off in vacuo, and the resulting product was purified by preparative HPLC to afford <b>56</b> (44 mg, 56%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.27 (1H, s), 8.08−7.99 (1H, m), 7.95−7.72 (4H, m), 7.59−7.51 (1H, m), 7.47−7.37 (2H, m), 5.68 (2H, m), 3.76−3.48 (8H, m), 3.37−3.24 (2H, m), 3.13−3.06 (9H, m), 2.92−2.79 (1H, m), 2.76−2.63 (7H, m), 2.13−1.99 (2H, m), 1.93−1.74 (3H, m), 1.73−1.60 (2H, m), 1.56−1.42 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>51</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 761.30; found, 761.2 [M]<sup>+</sup>. HPLC purity:  System B, 98.6%, <i>t</i><sub>R</sub> = 10.26 min. </div><div class="NLM_p"><b>{(</b><b><i>S</i></b><b>)-4-Amino-1-[2-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulf</b><b>onylamino]-cyclopentanecarbonyl}-piperazin-1-yl)-2-oxo-ethyl]-butyl}-trimethyl-ammoniu</b><b>m Trifluoroacetate Salt (57).</b> A solution of acid <b>4a</b> (58 mg, 0.11 mmol), HOAt (19 mg, 0.14 mmol), and EDAC (32 mg, 0.17 mmol) in DMF (2.0 mL) was stirred in an ice bath for 30 min. Then a solution of amine <b>26</b> (39 mg, 0.073 mmol) in DMF (2.0 mL) was added while stirring, followed by the dropwise addition of DIPEA (13 μL, 0.075 mmol). Stirring was continued at 0 °C for an additional 30 min, then at room temperature overnight. At the end of the reaction (HPLC control), the solvents were removed in vacuo, and the residue was dissolved in CH<sub>3</sub>CN/water + 0.1% TFA (1:1; 6.0 mL) and purified by preparative HPLC to obtain the Cbz-protected derivative (36.9 mg, 45%). A portion of this product (14.9 mg, 0.0133 mmol) was dissolved in TFA (1.5 mL), and triflic acid <a name="jm005000300563" id="jm005000300563"></a> (15 μL, 0.17 mmol) was added. At the end of the reaction (HPLC control), water (4.0 mL) was added, the resulting mixture was filtered, and the filtrate was purified by preparative HPLC to obtain <b>57</b> (15 mg, quantitative) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.25 (1H, s), 8.02 (1H, d), 7.79−7.69 (5H, m), 7.56−7.47 (1H, m), 7.44−7.32 (2H, m), 5.67 (2H, s), 3.74−3.54 (8H, m), 3.23−3.16 (1H, m), 3.09 (9H, s), 2.93−2.71 (4H, m), 2.68 (3H, s), 2.64 (3H, s), 2.14−2.00 (3H, m), 1.83−1.73 (2H, m), 1.72−1.55 (3H, m), 1.53−1.41 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>51</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 761.30; found, 761.3 [M]<sup>+</sup>. HPLC purity:  System B, 97.9%, <i>t</i><sub>R</sub> = 10.02 min. </div><div class="NLM_p"><b><i>N</i></b><b>-{1-[4-((</b><b><i>S</i></b><b>)-3-Amino-6-guanidino-hexanoyl)-piperazine-1-carbonyl]-cyclopentyl}-2,4-dichl</b><b>oro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonamide Trifluoroacetate Salt (58).</b> A solution of acid <b>17</b> (18 mg, 0.036 mmol) in DMF (2.0 mL) was cooled in an ice bath. EDAC (8.0 mg, 0.036 mmol) and HOAt (5.0 mg, 0.036 mmol) were added, and stirring was continued for 1 h. Amine <b>6a</b> (20 mg, 0.024 mmol) and DIPEA (9.0 μL, 0.048 mmol) were added, and the resulting mixture was stirred at room temperature overnight. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) and TFA (0.5 mL). After 12 h, the solvents were distilled off and the residue was purified by preparative HPLC to obtain <b>58</b> (6.0 mg, 23%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.44 (1H, s), 8.02 (1H, d), 7.79 (1H, d), 7.77−7.67 (3H, m), 7.50 (1H, t), 7.43 (1H, t), 7.37 (1H, d), 7.32 (1H, br s), 7.10−6.90 (4H, br s), 5.61 (2H, s), 3.77−3.41 (9H, m), 3.02 (2H, m), 2.79−2.68 (2H, m), 2.66 (3H, s), 2.59 (3H, s), 2.06−1.37 (12H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>5</sub>S, 760.27; found, 761.3 [M + H]<sup>+</sup>. HPLC purity:  System B, 91%, <i>t</i><sub>R</sub> = 9.02 min. </div><div class="NLM_p"><b>[2-(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cycl</b><b>opentanecarbonyl}-piperazin-1-yl)-2-oxo-ethyl]-trimethyl-ammonium Trifluoroacetate Salt </b><b>(59).</b> A solution of carboxymethyl-trimethyl-ammonium chloride (6.24 mg, 0.06 mmol), EDAC (15.2 mg, 0.17 mmol), and HOAt (23 mg, 0.17 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.04 mmol) and DIPEA (11 μL, 0.04 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvent was distilled off in vacuo and the crude product was purified by preparative HPLC to obtain <b>59</b> (27 mg, 73%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.27 (1H, s), 8.03 (1H, d), 7.77 (1H, d), 7.74−7.37 (4H, m), 5.69 (2H, s), 4.51 (2H, s), 3.75−3.47 (8H, m), 3.29 (9H, s), 2.70 (3H, s), 2.66 (3H, s), 2.11−2.01 (2H, m), 1.84−1.73 (2H, m), 1.53−1.43 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>42</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S, 690.23; found, 690.1 [M]<sup>+</sup>. HPLC purity:  System B, 98.1%, <i>t</i><sub>R</sub> = 9.64 min. </div><div class="NLM_p"><b>[4-(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cycl</b><b>opentanecarbonyl}-piperazin-1-yl)-4-oxo-butyl]-trimethyl-ammonium Trifluoroacetate Salt </b><b>(60).</b> A solution of (3-carboxypropyl)trimethylammonium chloride (10 mg, 0.068 mmol), EDAC (16 mg, 0.085 mmol), and HOAt (10 mg, 0.073 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.04 mmol) and DIPEA (14 μL, 0.05 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the crude product was purified by preparative HPLC to obtain <b>60</b> (21 mg, 55%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.25 (1H, s), 8.02 (1H, d), 7.82−7.70 (2H, m), 7.58−7.33 (3H, m), 5.68 (2H, s), 3.64 (4H, br s), 3.55 (4H, br s), 3.37−3.28 (2H, m), 3.10 (9H, s), 2.69 (3H, s), 2.65 (3H, s), 2.50−2.44 (2H, m), 2.11−1.73 (6H, m), 1.55−1.42 (4H, br s). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>46</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S, 718.24; found, 718.2 [M]<sup>+</sup>. HPLC purity:  System B, 97.6%, <i>t</i><sub>R</sub> = 9.71 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-3-Amino-4-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazin-1-yl)-4-oxo-butyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (61).</b> A solution of <b>10a</b> (13 mg, 0.05 mmol), EDAC (10 mg, 0.05 mmol), and HOAt (7.0 mg, 0.05 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (25 mg, 0.04 mmol) and DIPEA (11 μL, 0.04 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) and TFA (0.5 mL). After complete removal of the Boc group, the solvents were distilled off and the crude product was purified by preparative HPLC to obtain <b>61</b> (5 mg, 12%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.61 (1H, s), 8.32 (3H, br s), 8.02 (1H, d), 7.78 (1H, d), 7.81−7.35 (3H, m), 5.62 (2H, s), 4.58 (1H, br s), 3.85 (8H, m), 3.15 (9H, s), 2.72 (3H, s), 2.68 (3H, s), 2.22 (2H, m), 1.80 (2H, m), 1.60 (2H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 733.27; found, 733.2 [M]<sup>+</sup>. HPLC purity:  System B, 97%, <i>t</i><sub>R</sub> = 8.58 min. </div><div class="NLM_p"><b>[5-(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cycl</b><b>opentanecarbonyl}-piperazin-1-yl)-5-oxo-pentyl]-trimethyl-ammonium Trifluoroacetate </b><b>Salt (62).</b> A solution of (4-carboxybutyl)-trimethyl ammonium (7.0 mg, 0.04 mmol), EDAC (5.0 mg, 0.04 mmol), and HOAt (8.0 mg, 0.04 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (20 mg, 0.03 mmol) and DIPEA (8 μL, 0.03 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the crude product was purified by preparative HPLC to obtain <b>62</b> (20 mg, 69%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.39 (1H, s), 8.03 (1H, d), 7.78 (1H, d), 7.78−7.76 (1H, m), 7.60 (1H, t), 7.54−7.44 (2H, m), 5.65 (2H, s), 3.62 (4H, br s), 3.54 (4H, br s), 3.33−3.27 (2H, m), 3.05 (9H, s), 2.72 (3H, s), 2.68 (3H, s), 2.43 (2H, m), 2.06−1.99 (2H, m), 1.80−1.69 (4H, m), 1.60−1.53 (2H, m), 1.48−1.40 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>48</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S, 732.27; found, 732.4 [M]<sup>+</sup>. HPLC purity:  System B, 97.2%, <i>t</i><sub>R</sub> = 9.27 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-5-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazin-1-yl)-5-oxo-pentyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (63).</b> A solution of <b>10b</b> (19 mg, 0.07 mmol), EDAC (13 mg, 0.07 mmol), and HOAt (9.5 mg, 0.07 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (34 mg, 0.05 mmol) and DIPEA (24 μL, 0.09 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) and TFA (0.5 mL). When removal of the Boc group was complete, the solvents were distilled off and the crude product was purified by preparative HPLC to obtain <b>63</b> (15 mg, 27%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.33 (1H, s), 8.21 (3H, br s), 8.15 (1H, d), 7.78 (1H, d), 7.75 (1H, d), 7.58−7.50 (1H, t), 7.47−7.35 (2H, m), 5.64 (2H, s), 4.45 (1H, br s), 3.75 (8H, br s), 3.15 (9H, s), 2.72 (3H, s), 2.68 (2H, s), 1.77 (4H, m), 1.45 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 747.8; found, 747.3 [M]<sup>+</sup>. HPLC purity:  System B, 97%, <i>t</i><sub>R</sub> = 8.37 min. </div><div class="NLM_p"><b>[5-(4-(1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cycl</b><b>opentanecarbonyl]-piperazin-1-yl)-4(</b><b><i>S</i></b><b>)-trimethylammonio-5-oxo-pentyl]trimethyl-ammoni</b><b>um Trifluoroacetate Salt (64).</b> A solution of <b>14</b> (9.0 mg, 0.04 mmol), EDAC (5.0 mg, 0.04 mmol), and HOAt (8.0 mg, 0.04 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (20 mg, 0.03 mmol) and DIPEA (8 μL, 0.03 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the crude product was purified by preparative HPLC to obtain <b>64</b> (9.0 mg, 26%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.43 (1H, s), 8.03−8.00 (1H, d), 7.81−7.79 (1H, d), 7.75−7.73 (1H, d), 7.54 (1H, t), 7.44−7.37 (2H, m), 5.64 (2H, s), 4.65 (1H, d), 3.34 (2H, m), 3.20 (6H, s), 3.01 (9H, s), 2.81 (3H, s), 2.73 (3H, s), 2.68 (3H, s), 2.01 (2H, m), 1.77 (2H, m), 1.47 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 790.34; found, 777.5 [M − CH<sub>3</sub>]<sup>+</sup>. HPLC purity:  System B, >99%, <i>t</i><sub>R</sub> = 8.55 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-1-(4-{1-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-cyclopentanecarbonyl}-piperazine-1-carbonyl)-butyl]-trimethyl-ammonium </b><b><a name="jm005000300564" id="jm005000300564"></a> Trifluoroacetate Salt (65).</b> A solution of <b>12</b> (11 mg, 0.04 mmol), EDAC (6.0 mg, 0.04 mmol), and HOAt (8.0 mg, 0.04 mmol) in DMF (5.0 mL) was stirred in an ice bath. After 1 h, amine <b>6a</b> (30 mg, 0.04 mmol) and DIPEA (11 μL 0.04 mmol) were added and stirring was continued overnight at room temperature. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) and TFA (0.5 mL). When removal of the Boc group was complete, the solvents were distilled off and the crude product was purified by preparative HPLC to obtain <b>65</b> (18 mg, 41%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.43 (1H, s), 8.03 (1H, d), 7.80−7.78 (2H, d), 7.74−7.72 (2H, d), 7.54 (1H, t), 7.43−7.38 (2H, m), 5.64 (2H, s), 4.69 (2H, d), 3.20 (9H, s), 2.85 (2H, s), 2.68 (3H, s), 2.63 (3H, s), 2.00 (2H, m), 1.76 (2H, m), 1.46 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S, 747.28; found, 747.3 [M]<sup>+</sup>. HPLC purity:  System B, 98.7%, <i>t</i><sub>R</sub> = 8.64 min. </div><div class="NLM_p"><b>4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cyclope</b><b>ntanecarbonyl}-</b><b><i>N</i></b><b>-(3-dimethyl-amino-propyl)-piperazine-1-carboxamidine Trifluoroacetate </b><b>Salt (66).</b> A solution of acid <b>4a</b> (78 mg, 0.15 mmol), HOAt (20 mg, 0.15 mmol), and EDAC (28.5 mg, 0.15 mmol) in DMF (3.0 mL) was stirred at room temperature for 25 min. Then a solution of amine <b>38</b> (40 mg, 0.124 mmol) and DIPEA (65 μL, 0.37 mmol) in DMF (2.0 mL) was added and stirring was continued at room temperature overnight. At the end of the reaction (HPLC control), the solution was concentrated to 2.5 mL and purified by HPLC to give <b>66</b> (80 mg, 50%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.78−9.40 (1H, br s), 8.35−8.22 (1H, m), 8.06−7.94 (1H, m), 7.82−7.57 (5H, m), 7.57−7.46 (1H, m), 7.46−7.32 (2H, m), 5.71−5.63 (2H, m), 3.80−3.66 (4H, m), 3.59−3.48 (4H, m), 3.36−3.26 (2H, m), 3.15−3.06 (2H, m), 2.86−2.78 (6H, m), 2.73−2.58 (6H, m), 2.12−1.98 (2H, m), 1.98−1.87 (2H, m), 1.83−1.72 (2H, m), 1.54−1.41 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>4</sub>S, 717.26; found, 718.2 [M + H]<sup>+</sup>. HPLC purity:  System B, 93.4%, <i>t</i><sub>R</sub> = 10.14 min. </div><div class="NLM_p"><b>{3-[(4-{1-[2,4-Dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfonylamino]-cyc</b><b>lopentanecarbonyl}-piperazine-1-carboximidoyl)-amino]-propyl}-trimethyl-ammonium </b><b>Trifluoroacetate Salt (67).</b> An ice-cold solution of <b>4a</b> (121 mg, 0.23 mmol), HOAt (31 mg, 0.23 mmol), and EDAC (44 mg, 0.23 mmol) in DMF (5.0 mL) was stirred for 20 min. Then a solution of the amine <b>40</b> (65 mg, 0.19 mmol) and DIPEA (19 μL, 0.57 mmol) in DMF (2.0 mL) was added. At the end of the reaction, the solvents were distilled off in vacuo and the crude product was purified by preparative HPLC to afford <b>67</b> (7.5 mg, 4%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.37−8.26 (1H, m), 8.07−7.98 (1H, m), 7.83−7.66 (4H, m), 7.56−7.46 (1H, m), 7.44−7.31 (2H, m), 5.73−5.64 (2H, m), 3.82−3.71 (4H, m), 3.62−3.52 (5H, m), 3.41−3.26 (4H, m), 3.18−3.06 (9H, m), 2.74−2.60 (6H, m), 2.14−1.96 (5H, m), 1.85−1.73 (2H, m), 1.56−1.43 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>48</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>4</sub>S, 732.29; found, 732.1 [M]<sup>+</sup>. HPLC purity:  System B, 98.5%, <i>t</i><sub>R</sub> = 9.90 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-tetrahydro-thiopyran-4-carbonyl}-piperazin-1-yl)-5-oxo-pentyl]-trimethyl-ammoni</b><b>um Trifluoroacetate Salt (68).</b> A solution of the acid <b>10b</b> (36 mg, 0.13 mmol), EDAC (75 mg, 0.39 mmol), and HOAt (18 mg, 0.13 mmol) in DMF (3.0 mL) was stirred at room temperature for 1 h. Then a solution of amine <b>6d</b> (86 mg, 0.13 mmol) and DIPEA (44 μL, 0.26 mmol) in DMF (1.0 mL) was added and stirring was continued for 1 h. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in TFA (2.0 mL) and stirred at room temperature for 40 min. Et<sub>2</sub>O was added with stirring and a product was precipitated that was filtered off. Purification by preparative HPLC afforded <b>68</b> (14 mg, 11%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.80 (1H, s), 8.0−7.40 (6H, m), 5.60 (1H, s), 4.55 (1H, s), 3.80−3.30 (8H, m), 3.0 (9H, s), 2.70 6H, s), 2.40−2.00 (8H, m), 1.75 (4H, d). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>5</sub>S<sub>2</sub>, 779.25; found, 779.2 [M]<sup>+</sup>. HPLC purity:  System A, >99%, <i>t</i><sub>R</sub> = 7.52 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-piperidine-4-carbonyl}-piperazin-1-yl)-5-oxo-pentyl]-trimethyl-ammonium </b><b>Trifluoroacetate Salt (69).</b> A solution of the acid <b>10b</b> (10 mg, 0.036 mmol), EDAC (26 mg, 0.036 mmol), and HOAt (6.0 mg, 0.044 mmol) in DMF (3.0 mL) was stirred at room temperature for 1 h. Amine <b>6e</b> (26 mg, 0.036 mmol) and DIPEA (15 μL, 0.088 mmol) in DMF (1.0 mL) were added and stirring was continued for 1.5 h. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1; 4.0 mL) and stirred at room temperature for 40 min. The solvents were distilled off in vacuo, and the residue was purified by preparative HPLC to afford <b>69</b> (14.9 mg) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 9.20 (1H, s), 8.50 (2H, s), 8.25 (3H, s), 8.10−7.30 (6H, m), 5.60 (1H, s), 4.55 (1H, s), 4.00−3.30 (8H, m), 3.30−2.90 (13H, m), 2.80−2.55 (9H, m), 2.25−1.70 (8H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>50</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>5</sub>S, 762.29; found, 762.3 [M]<sup>+</sup>. HPLC purity:  System A, >99%, <i>t</i><sub>R</sub> = 5.17 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-4-Amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-1-methyl-piperidine-4-carbonyl}-piperazin-1-yl)-5-oxo-pentyl]-trimethyl-ammoniu</b><b>m Trifluoroacetate Salt (70).</b> Crude <b>6e</b> (114 mg, 0.072 mmol) was dissolved in dry DMF (1 mL), and DIPEA was added until the pH was about 7. Acid <b>10</b> (22 mg, 0.079 mmol), HOAt (10.8 mg, 0.079 mmol), EDAC (15.2 mg, 0.079 mmol), and DIPEA (13.5 μL, 0.079 mmol) were added, and the mixture was stirred at room temperature overnight. The solvents were distilled off under reduced pressure, the residue was dissolved in dry DCM (1.5 mL), and TFA (1.5 mL) was added dropwise while stirring, After 30 min, the solvents were distilled off and the residue was purified by preparative HPLC to obtain <b>70</b> (15 mg, 21%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 353 °K):  δ 8.90 (1H, s), 8.19 (2H, br s), 8.05 (1H, d, <i>J</i> = 8.7 Hz), 7.80 (1H, d, <i>J</i> = 8.7 Hz), 7.74 (1H, d, <i>J</i> = 8.3 Hz), 7.52 (1H, t, <i>J</i> = 8.1 Hz), 7.41 (1H, d, <i>J</i> = 7.7 Hz), 7.33 (1H, s), 5.66 (2H, s), 4.47 (1H, s), 4.13−3.38 (12H, covered by water), 3.38−3.27 (2H, m), 3.07 (9H, s), 2.69−2.64 (6H, m), 2.61 (3H, s), 2.38−1.95 (4H, m), 1.89−1.70 (4H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>52</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>5</sub>S, 776.31; found, 776.3 [M]<sup>+</sup>. HPLC purity:  System A, >99%, <i>t</i><sub>R</sub> = 8.20 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-5-(4-{1-Acetyl-4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-piperidine-4-carbonyl}-piperazin-1-yl)-4-amino-5-oxo-pentyl]-trimethyl-ammoniu</b><b>m Trifluoroacetate Salt (71).</b> A solution of acid <b>10</b> (8.0 mg, 0.026 mmol), HOAt (4.0 mg, 0.026 mmol), EDAC (5.6 mg, 0.026 mmol), and DIPEA (4.5 μL, 0.026 mmol) in DMF (2 mL) was stirred at room temperature for 1 h and then added to crude <b>6f</b> (18 mg, 0.025 mmol) dissolved in dry DMF (1 mL). At the end of the reaction (HPLC control), the solvents were distilled off under reduced pressure and the residue was dissolved in DCM/TFA (1:1; 2 mL) and stirred for 2 h. The solvents were distilled off, and the crude product was purified by preparative HPLC to obtain <b>71</b> (10 mg, 38%) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 353 °K):  δ 8.55 (1H, s), 8.15 (2H, br s), 8.02 (1H, d, <i>J</i> = 8.7 Hz), 7.77 (1H, d, <i>J</i> = 8.7 Hz), 7.70 (1H, d, <i>J</i> = 8.2 Hz), 7.47 (1H, t, <i>J</i> = 8.2 Hz), 7.36−7.29 (2H, m), 5.67 (2H, s), 4.46 (1H, s), 3.93−3.56 (8H, m), 3.55−3.06 (6H, m, covered by water), 3.07 (9H, s), 2.65 (3H, s), 2.61 (3H, s), 1.89 (3H, s), 1.85−1.71 (8H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>52</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>6</sub>S, 804.3; found, 804.2 [M]<sup>+</sup>. HPLC purity:  System B, 97%, <i>t</i><sub>R</sub> = 14.23 min. </div><div class="NLM_p"><b>[(</b><b><i>S</i></b><b>)-5-Amino-6-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)-benzenesulfony</b><b>lamino]-tetrahydro-pyran-4-carbonyl}-piperazin-1-yl)-6-oxo-pentyl]-trimethyl-ammonium </b><b>Hydrochloride Salt (72).</b> A solution of the acid <b>10</b> (75 mg, 0.27 mmol), EDAC (62 mg, 0.32 mmol), and HOAt (44 mg, 0.32 mmol) in DMF (3.0 mL) was stirred at room temperature for 1 h. Amine <b>6b</b> (150 mg, 0.18 mmol) and DIPEA (110 μL, 0.6 mmol) in DMF (1.0 mL) were added, and stirring was continued for 20 h. At the end of the reaction (HPLC control), the solvents were distilled off in vacuo and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with 5% NaHCO<sub>3</sub> and satd NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residual oil was dissolved in a small <a name="jm005000300565" id="jm005000300565"></a> volume of CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) and precipitated with Et<sub>2</sub>O. Filtration gave the crude Boc-protected derivative (145 mg, 0.17 mmol, 94%). This was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3.0 mL), and 4 N HCl in dioxane (3.0 mL) was added. After stirring at room temperature for 30 min, the solvents were removed in vacuo. Trituration of the residue with Et<sub>2</sub>O afforded <b>72 </b>(<b>MEN </b><b>16132</b>; 110 mg, 73%) as the hydrochloride salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>):  δ 8.85 (1H, s), 8.50 (3H, s), 8.02 (1H, d), 7.90−7.60 (4H, m), 5.59 (2H, s), 4.57−4.45 (1H, m), 3.70−3.18 (12H, m), 3.08 (9H, s), 2.81 (6H, m), 1.95−1.60 (8H, m). MS <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>6</sub>S, 763.2; found, 763.1 [M]<sup>+</sup>. HPLC purity:  System B, 97%, <i>t</i><sub>R</sub> = 7.40 min. </div><div class="NLM_p"><b>(B) Biology.</b> The receptor binding assays and the measurement of inositol monophosphate accumulation were carried out as described in ref 11. The measurement of the antagonist potency (p<i>A</i><sub>2</sub>) in the BK-induced contraction of the GPI was performed as described in ref 13. </div><div class="NLM_p last">In vivo experiments were performed in male Dunkin Hartley guinea pigs weighing 350−400 g (Charles River, Italy) in accordance with the European Union and the local ethical commitee regulations. Evaluation of bronchoconstriction and hypotension induced by iv bradykinin and the antagonist effects of the compounds were performed according to the methods reported in ref 16. </div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Fattori</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Rossi</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher I. Fincham</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerio Caciagli</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Catrambone</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piero D'Andrea</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrizia Felicetti</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Gensini</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Marastoni</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rossano Nannicini</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marielle Paris</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosa Terracciano</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Bressan</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandro Giuliani</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlo A. Maggi</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Meini</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Valenti</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Quartara</span> - <span class="hlFld-Affiliation affiliation">Menarini Ricerche, Via Tito Speri 10, 00040 Pomezia (Rome), Italy, and Menarini Ricerche, Via Rismondo 12A, 50131 Florence, Italy </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm061143k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Mr. Ricci and Mr. Fabbri for technical assistance, to Dr. A. Cartoni, Dr. A. Triolo, and Dr. S. Mauro for analytical assistance, and to Dr. A. Ettorre and Dr. G. Balacco for the NMR spectra. This work was supported by grants from the Italian Ministry of University and Research (RIF.506/DSPAR 98). </p></div><div class="NLM_fn" id="jm061143kn00001"><p class="first last">Abbreviations:  AcOH, acetic acid; AcCN, acetonitrile; BSA, <i>N</i>,<i>O</i>-bis-trimethylsilylacetamide; DIAD, diisopropyl azodicarboxylate; DIPEA, diisopropylethyl amine; DCM, dichloromethane; DMF, dimethylformamide; DMSO, dimethylsulfoxide; EDAC, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>‘-ethylcarbodiimide; EtOAc, ethyl acetate; Et<sub>2</sub>O, diethyl ether; EtOH, ethanol; HOAt, 7-aza-1-hydroxybenzotriazole; HOBt, 1-hydroxybenzotriazole; MeOH, methanol; NBS, <i>N</i>-bromosuccinimide; PyBOP, (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate; TFA, trifluoroacetic acid; THF, tetrahydrofuran; TMSCl, trimethylsilyl chloride.</p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 16 other publications.
        </p><ol id="references" class="useLabel"><li id="jm061143kb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm061143kb00001_1"><span><span class="NLM_string-ref">Mak, J. C. W.; Barnes, P. J. Autoradiographic visualization of bradykinin receptors in human and guinea-pig lung. <i>  Eur. J. Pharmacol.</i><b>1991</b>, <i>194</i>, 37−43.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1991&pages=43&author=J.+C.+W.+Mak&author=P.+J+Barnes&title=Autoradiographic+visualization+of+bradykinin+receptors+in+human+and+guinea-pig+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DJ.%2BC.%2BW.%26atitle%3DAutoradiographic%2520visualization%2520of%2520bradykinin%2520receptors%2520in%2520human%2520and%2520guinea-pig%2520lung%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D194%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm061143kb00002_1"><span><span class="NLM_string-ref">Dear, J. W.; Wirth, K.; Scadding, G. K.; Foreman, J. C. Characterization of the bradykinin receptor in the human nasal airway using the binding of [<sup>125</sup>I]-Hoe 140. <i>  Br. J. Pharmacol.</i><b>1996</b>, <i>119</i>, 1054−1062.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1062&author=J.+W.+Dear&author=K.+Wirth&author=G.+K.+Scadding&author=J.+C+Foreman&title=Characterization+of+the+bradykinin+receptor+in+the+human+nasal+airway+using+the+binding+of+%5B125I%5D-Hoe+140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDear%26aufirst%3DJ.%2BW.%26atitle%3DCharacterization%2520of%2520the%2520bradykinin%2520receptor%2520in%2520the%2520human%2520nasal%2520airway%2520using%2520the%2520binding%2520of%2520%255B125I%255D-Hoe%2520140%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm061143kb00003_1"><span><span class="NLM_string-ref">Polosa, R.; Holgate, S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg<sup>9</sup>]bradykinin in normal and asthmatic subjects.<i> Eur. J. Pharmacol.</i><b>1989</b>, <i>163</i>, 195−197.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1989&pages=197&author=R.+Polosa&author=S.+T+Holgate&title=Comparative+airway+response+to+inhaled+bradykinin%2C+kallidin%2C+and+%5Bdes-Arg9%5Dbradykinin+in+normal+and+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolosa%26aufirst%3DR.%26atitle%3DComparative%2520airway%2520response%2520to%2520inhaled%2520bradykinin%252C%2520kallidin%252C%2520and%2520%255Bdes-Arg9%255Dbradykinin%2520in%2520normal%2520and%2520asthmatic%2520subjects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1989%26volume%3D163%26spage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm061143kb00004_1"><span><span class="NLM_string-ref">Churchill, L.; Pongracic, J. A.; Reynolds, C. J.; Naclerio, R. M.; Proud, D. Pharmacology of nasal provocation with bradykinin:  Studies of tachyphylaxis, cyclooxygenase inhibition, α-adrenergic stimulation and receptor subtype. <i>  Int. Arch. Allergy Appl. Immunol.</i><b>1991</b>,<i> 95</i>, 322−331.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1991&pages=331&author=L.+Churchill&author=J.+A.+Pongracic&author=C.+J.+Reynolds&author=R.+M.+Naclerio&author=D+Proud&title=Pharmacology+of+nasal+provocation+with+bradykinin%3A%E2%80%89+Studies+of+tachyphylaxis%2C+cyclooxygenase+inhibition%2C+%CE%B1-adrenergic+stimulation+and+receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChurchill%26aufirst%3DL.%26atitle%3DPharmacology%2520of%2520nasal%2520provocation%2520with%2520bradykinin%253A%25E2%2580%2589%2520Studies%2520of%2520tachyphylaxis%252C%2520cyclooxygenase%2520inhibition%252C%2520%25CE%25B1-adrenergic%2520stimulation%2520and%2520receptor%2520subtype%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Appl.%2520Immunol.%26date%3D1991%26volume%3D95%26spage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm061143kb00005_1"><span><span class="NLM_string-ref">Shibayama, Y; Skoner, D.; Suehiro, S.; Konishi, J. E.; Fireman, P.; Kaplan, A. P. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. <i>  Immunopharmacology</i><b>1996</b>, <i>33</i>, 311−313.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=313&author=+Shibayama&author=S.+Suehiro&author=J.+E.+Konishi&author=P.+Fireman&author=A.+P+Kaplan&title=Bradykinin+levels+during+experimental+nasal+infection+with+rhinovirus+and+attenuated+influenza+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShibayama%26atitle%3DBradykinin%2520levels%2520during%2520experimental%2520nasal%2520infection%2520with%2520rhinovirus%2520and%2520attenuated%2520influenza%2520virus%26jtitle%3DImmunopharmacology%26date%3D1996%26volume%3D33%26spage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm061143kb00006_1"><span><span class="NLM_string-ref">Svensson, C.; Andresson, M.; Persson, C. G.; Venge, P.; Alkner, U.; Pipkorn, U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.<i> J. Allergy Clin. Immunol.</i><b>1990</b>, <i>85</i>, 828−833.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1990&pages=833&author=C.+Svensson&author=M.+Andresson&author=C.+G.+Persson&author=P.+Venge&author=U.+Alkner&author=U.+Pipkorn&author=+Albumin&title=and+eosinophil+cationic+protein+on+the+nasal+mucosal+surface+in+patients+with+hay+fever+during+natural+allergen+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%26atitle%3Dand%2520eosinophil%2520cationic%2520protein%2520on%2520the%2520nasal%2520mucosal%2520surface%2520in%2520patients%2520with%2520hay%2520fever%2520during%2520natural%2520allergen%2520exposure%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D1990%26volume%3D85%26spage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm061143kb00007_1"><span><span class="NLM_string-ref">Akbary, A. M.; Wirth, K. J.; Scholkens, B. A. Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. <i>  Immunopharmacology</i><b>1996</b>, <i>33</i>, 238−242.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=242&author=A.+M.+Akbary&author=K.+J.+Wirth&author=B.+A+Scholkens&title=Efficacy+and+tolerability+of+Icatibant+%28Hoe+140%29+in+patients+with+moderately+severe+chronic+bronchial+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkbary%26aufirst%3DA.%2BM.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520Icatibant%2520%2528Hoe%2520140%2529%2520in%2520patients%2520with%2520moderately%2520severe%2520chronic%2520bronchial%2520asthma%26jtitle%3DImmunopharmacology%26date%3D1996%26volume%3D33%26spage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm061143kb00008_1"><span><span class="NLM_string-ref">Austin, C. E.; Foreman, J. C.; Scadding, G. K. Reduction by Hoe 140, the B<sub>2</sub> kinin receptor antagonist, of antigen-induced nasal blockage.<i> Br. J. </i><i>Pharmacol.</i><b>1994</b>, <i>111</i>, 969−971.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1994&pages=971&author=C.+E.+Austin&author=J.+C.+Foreman&author=G.+K+Scadding&title=Reduction+by+Hoe+140%2C+the+B2+kinin+receptor+antagonist%2C+of+antigen-induced+nasal+blockage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DC.%2BE.%26atitle%3DReduction%2520by%2520Hoe%2520140%252C%2520the%2520B2%2520kinin%2520receptor%2520antagonist%252C%2520of%2520antigen-induced%2520nasal%2520blockage%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D111%26spage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm061143kb00009_1"><span><span class="NLM_string-ref">Kuoppala, A.; Lindsted, K. A.; Saarinen, J.; Kovanen, P. T.; Kokkonen, J. O. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. <i>  Am. J. Physiol.</i><b>2000</b>, <i>278 </i>(4), H1069−1074.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2000&pages=1074&issue=4&author=A.+Kuoppala&author=K.+A.+Lindsted&author=J.+Saarinen&author=P.+T.+Kovanen&author=J.+O+Kokkonen&title=Inactivation+of+bradykinin+by+angiotensin-converting+enzyme+and+by+carboxypeptidase+N+in+human+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuoppala%26aufirst%3DA.%26atitle%3DInactivation%2520of%2520bradykinin%2520by%2520angiotensin-converting%2520enzyme%2520and%2520by%2520carboxypeptidase%2520N%2520in%2520human%2520plasma%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2000%26volume%3D278%26issue%3D4%26spage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00010"><div class="reference"><div class="NLM_citation" id="jm061143kb00010_1"><span><span class="NLM_string-ref">Campbell, D. J.; Krum, H.; Esler, M. D. Losartan increases bradykinin levels in hypertensive humans. <i>  Circulation</i><b>2005</b>, <i>111</i>, 315−320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=320&author=D.+J.+Campbell&author=H.+Krum&author=M.+D+Esler&title=Losartan+increases+bradykinin+levels+in+hypertensive+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DD.%2BJ.%26atitle%3DLosartan%2520increases%2520bradykinin%2520levels%2520in%2520hypertensive%2520humans%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm061143kb00011_1"><span><span class="NLM_string-ref">Fattori, D.; Rossi, C.; Fincham, C. I.; Berettoni, M.; Calvani, F.; Catrambone, F.; Felicetti, P.; Gensini, M.; Terracciano, R.; Altamura, M.; Bressan, A.; Giuliani, S.; Maggi, C. A.; Meini, S.; Valenti, C.; Quartara, L. Design and synthesis of novel sulfonamide-containing bradykinin hB<sub>2</sub> receptor antagonists. 1. Synthesis and SAR of α,α-dimethylglycine sulfonamides.<i> J. Med. Chem.</i><b>2006</b>, <i>49</i>, 3602−3613.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3613&author=D.+Fattori&author=C.+Rossi&author=C.+I.+Fincham&author=M.+Berettoni&author=F.+Calvani&author=F.+Catrambone&author=P.+Felicetti&author=M.+Gensini&author=R.+Terracciano&author=M.+Altamura&author=A.+Bressan&author=S.+Giuliani&author=C.+A.+Maggi&author=S.+Meini&author=C.+Valenti&author=L+Quartara&title=Design+and+synthesis+of+novel+sulfonamide-containing+bradykinin+hB2+receptor+antagonists.+1.+Synthesis+and+SAR+of+%CE%B1%2C%CE%B1-dimethylglycine+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFattori%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520sulfonamide-containing%2520bradykinin%2520hB2%2520receptor%2520antagonists.%25201.%2520Synthesis%2520and%2520SAR%2520of%2520%25CE%25B1%252C%25CE%25B1-dimethylglycine%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm061143kb00012_1"><span><span class="NLM_string-ref">Sum of residual BK-induced response calculated in percentage with respect to the basal response and normalized in comparison to the control registered at the various times of observation (5−30−60−90−120−180−210 min), further calculated in percentages with respect to the theoretical maximum. As a consequence, the maximal inhibition that may be obtained corresponds to Σ% = 0, while the absence of inhibition corresponds to Σ% = 100.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Sum+of+residual+BK-induced+response+calculated+in+percentage+with+respect+to+the+basal+response+and+normalized+in+comparison+to+the+control+registered+at+the+various+times+of+observation+%285%E2%88%9230%E2%88%9260%E2%88%9290%E2%88%92120%E2%88%92180%E2%88%92210+min%29%2C+further+calculated+in+percentages+with+respect+to+the+theoretical+maximum.+As+a+consequence%2C+the+maximal+inhibition+that+may+be+obtained+corresponds+to+%CE%A3%25+%3D+0%2C+while+the+absence+of+inhibition+corresponds+to+%CE%A3%25+%3D+100.+Sum+of+residual+BK-induced+response+calculated+in+percentage+with+respect+to+the+basal+response+and+normalized+in+comparison+to+the+control+registered+at+the+various+times+of+observation+%285%E2%88%9230%E2%88%9260%E2%88%9290%E2%88%92120%E2%88%92180%E2%88%92210+min%29%2C+further+calculated+in+percentages+with+respect+to+the+theoretical+maximum.+As+a+consequence%2C+the+maximal+inhibition+that+may+be+obtained+corresponds+to+%CE%A3%25+%3D+0%2C+while+the+absence+of+inhibition+corresponds+to+%CE%A3%25+%3D+100."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm061143kb00013_1"><span><span class="NLM_string-ref">Cucchi, P.; Meini, S.; Bressan, A.; Catalani, C.; Bellucci, F.; Santicioli, P.; Lecci, A.; Faiella, A.; Rotondaro, L.; Giuliani, S.; Giolitti, A.; Quartara, L.; Maggi, C. A. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. <i>  Eur. J. Pharmacol.</i><b>2005</b>, <i>528</i>, 7−16.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=528&publication_year=2005&pages=16&author=P.+Cucchi&author=S.+Meini&author=A.+Bressan&author=C.+Catalani&author=F.+Bellucci&author=P.+Santicioli&author=A.+Lecci&author=A.+Faiella&author=L.+Rotondaro&author=S.+Giuliani&author=A.+Giolitti&author=L.+Quartara&author=C.+A.+Maggi&title=a+novel+potent+and+selective+nonpeptide+antagonist+for+the+human+bradykinin+B2+receptor.+In+vitro+pharmacology+and+molecular+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCucchi%26aufirst%3DP.%26atitle%3Da%2520novel%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520for%2520the%2520human%2520bradykinin%2520B2%2520receptor.%2520In%2520vitro%2520pharmacology%2520and%2520molecular%2520characterization%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D528%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm061143kb00014_1"><span><span class="NLM_string-ref">(a) McAllistar, S. M.; Alpar, H. O.; Teitelbaum, Z.; Bennet, D. B. Do interactions with phospholipids contribute to the prolonged retention of polypeptides within lungs? <i>Adv. Drug Delivery Rev.</i><b>1996</b>, <i>19</i>, 89−110.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=110&author=S.+M.+McAllistar&author=H.+O.+Alpar&author=Z.+Teitelbaum&author=D.+B+Bennet&title=Do+interactions+with+phospholipids+contribute+to+the+prolonged+retention+of+polypeptides+within+lungs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllistar%26aufirst%3DS.%2BM.%26atitle%3DDo%2520interactions%2520with%2520phospholipids%2520contribute%2520to%2520the%2520prolonged%2520retention%2520of%2520polypeptides%2520within%2520lungs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1996%26volume%3D19%26spage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm061143kb00014_2"><span><span class="NLM_string-ref">(b) Upton, R. N.; Doolette, D. J. Kinetic aspects of drug disposition in the lungs. <i>  Clin. Exp. Pharmacol. Physiol.</i><b>1999</b>, <i>26</i>, 381−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=391&author=R.+N.+Upton&author=D.+J+Doolette&title=Kinetic+aspects+of+drug+disposition+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00014_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUpton%26aufirst%3DR.%2BN.%26atitle%3DKinetic%2520aspects%2520of%2520drug%2520disposition%2520in%2520the%2520lungs%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1999%26volume%3D26%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm061143kb00015_1"><span><span class="NLM_string-ref">Barnes, P. G. Tiotropium Bromide. <i>  Exp. Opin. Inv. Drugs</i><b>2001</b>, <i>10</i>, 733−740.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Barnes%2C+P.+G.+Tiotropium+Bromide.+Exp.+Opin.+Inv.+Drugs+2001%2C+10%2C+733%E2%88%92740.+Barnes%2C+P.+G.+Tiotropium+Bromide.+Exp.+Opin.+Inv.+Drugs2001%2C+10%2C+733%E2%88%92740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BG.%26jtitle%3DExp.%2520Opin.%2520Inv.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm061143kb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm061143kb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm061143kb00016_1"><span><span class="NLM_string-ref">Valenti, C.; Cialdai, C.; Giuliani, S.; Lecci, A.; Tramontana, M.; Meini, S.; Quartara, L.; Maggi, C. A. MEN 16132, a novel, potent and selective non-peptide kinin B<sub>2</sub> receptor antagonist. In vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs. <i>  J. Pharmacol. Exp. Ther.</i><b>2005</b>, 616−623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=616&publication_year=2005&pages=623&author=C.+Valenti&author=C.+Cialdai&author=S.+Giuliani&author=A.+Lecci&author=M.+Tramontana&author=S.+Meini&author=L.+Quartara&author=C.+A.+Maggi&title=potent+and+selective+non-peptide+kinin+B2+receptor+antagonist.+In+vivo+activity+on+bradykinin-induced+bronchoconstriction+and+nasal+mucosa+microvascular+leakage+in+anesthetized+guinea+pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DC.%26atitle%3Dpotent%2520and%2520selective%2520non-peptide%2520kinin%2520B2%2520receptor%2520antagonist.%2520In%2520vivo%2520activity%2520on%2520bradykinin-induced%2520bronchoconstriction%2520and%2520nasal%2520mucosa%2520microvascular%2520leakage%2520in%2520anesthetized%2520guinea%2520pigs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D616%26spage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm061143kb00001':['jm061143kb00001_1'],'jm061143kb00002':['jm061143kb00002_1'],'jm061143kb00003':['jm061143kb00003_1'],'jm061143kb00004':['jm061143kb00004_1'],'jm061143kb00005':['jm061143kb00005_1'],'jm061143kb00006':['jm061143kb00006_1'],'jm061143kb00007':['jm061143kb00007_1'],'jm061143kb00008':['jm061143kb00008_1'],'jm061143kb00009':['jm061143kb00009_1'],'jm061143kb00010':['jm061143kb00010_1'],'jm061143kb00011':['jm061143kb00011_1'],'jm061143kb00012':['jm061143kb00012_1'],'jm061143kb00013':['jm061143kb00013_1'],'jm061143kb00014':['jm061143kb00014_1','jm061143kb00014_2'],'jm061143kb00015':['jm061143kb00015_1'],'jm061143kb00016':['jm061143kb00016_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Gibson</span>, <span class="hlFld-ContribAuthor ">Karsten  Schnatbaum</span>, <span class="hlFld-ContribAuthor ">Jochen R.  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Elsa  Locardi</span>, <span class="hlFld-ContribAuthor ">Matthias  Paschke</span>, <span class="hlFld-ContribAuthor ">Ulf  Reimer</span>, <span class="hlFld-ContribAuthor ">Uwe  Richter</span>, <span class="hlFld-ContribAuthor ">Dirk  Scharn</span>, <span class="hlFld-ContribAuthor ">Alexander  Faussner</span> and <span class="hlFld-ContribAuthor ">Thomas  Tradler</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule Bradykinin B2 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (14)
                                     , 4370-4379. <a href="https://doi.org/10.1021/jm9002445" title="DOI URL">https://doi.org/10.1021/jm9002445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9002445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9002445%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSmall%252BMolecule%252BBradykinin%252BB2%252BReceptor%252BAntagonists%26aulast%3DGibson%26aufirst%3DChristoph%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D26022009%26date%3D24062009%26date%3D23072009%26volume%3D52%26issue%3D14%26spage%3D4370%26epage%3D4379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asmaa M.  Fahim</span>, <span class="hlFld-ContribAuthor ">Eman H. I.  Ismael</span>, <span class="hlFld-ContribAuthor ">Ghada H.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Ahmad M.  Farag</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antimicrobial, anti-proliferative activities, molecular docking and DFT studies of novel pyrazolo[5,1-c][1, 2, 4]triazine-3-carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>10 </em>, 1-17. <a href="https://doi.org/10.1080/07391102.2021.1930582" title="DOI URL">https://doi.org/10.1080/07391102.2021.1930582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1930582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1930582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DSynthesis%25252C%252Bantimicrobial%25252C%252Banti-proliferative%252Bactivities%25252C%252Bmolecular%252Bdocking%252Band%252BDFT%252Bstudies%252Bof%252Bnovel%252Bpyrazolo%25255B5%25252C1-c%25255D%25255B1%25252C%252B2%25252C%252B4%25255Dtriazine-3-carboxamide%252Bderivatives%26aulast%3DFahim%26aufirst%3DAsmaa%2BM.%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher I.  Fincham</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bressan</span>, <span class="hlFld-ContribAuthor ">Piero  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Alessandro  Ettorre</span>, <span class="hlFld-ContribAuthor ">Sandro  Giuliani</span>, <span class="hlFld-ContribAuthor ">Sandro  Mauro</span>, <span class="hlFld-ContribAuthor ">Stefania  Meini</span>, <span class="hlFld-ContribAuthor ">Marielle  Paris</span>, <span class="hlFld-ContribAuthor ">Laura  Quartara</span>, <span class="hlFld-ContribAuthor ">Cristina  Rossi</span>, <span class="hlFld-ContribAuthor ">Antonella  Squarcia</span>, <span class="hlFld-ContribAuthor ">Claudio  Valenti</span>, <span class="hlFld-ContribAuthor ">Fattori  Daniela</span>, <span class="hlFld-ContribAuthor ">Carlo Alberto  Maggi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (6)
                                     , 2091-2100. <a href="https://doi.org/10.1016/j.bmc.2012.01.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.01.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.01.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bsulfonamide-containing%252Bbradykinin%252BhB2%252Breceptor%252Bantagonists.%252BSynthesis%252Band%252Bstructure-relationships%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B1-tetrahydropyranylglycine%26aulast%3DFincham%26aufirst%3DChristopher%2BI.%26date%3D2012%26volume%3D20%26issue%3D6%26spage%3D2091%26epage%3D2100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Meini</span>, <span class="hlFld-ContribAuthor ">F  Bellucci</span>, <span class="hlFld-ContribAuthor ">C  Catalani</span>, <span class="hlFld-ContribAuthor ">P  Cucchi</span>, <span class="hlFld-ContribAuthor ">A  Giolitti</span>, <span class="hlFld-ContribAuthor ">S  Giuliani</span>, <span class="hlFld-ContribAuthor ">L  Quartara</span>, <span class="hlFld-ContribAuthor ">L  Rotondaro</span>, <span class="hlFld-ContribAuthor ">S  Zappitelli</span>, <span class="hlFld-ContribAuthor ">CA  Maggi</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2011,</strong> <em>162 </em>
                                    (5)
                                     , 1202-1212. <a href="https://doi.org/10.1111/j.1476-5381.2010.01133.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2010.01133.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2010.01133.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2010.01133.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DComparison%252Bof%252Bthe%252Bmolecular%252Binteractions%252Bof%252Btwo%252Bantagonists%25252C%252BMEN16132%252Bor%252Bicatibant%25252C%252Bat%252Bthe%252Bhuman%252Bkinin%252BB2%252Breceptor%26aulast%3DMeini%26aufirst%3DS%26date%3D2011%26date%3D2011%26volume%3D162%26issue%3D5%26spage%3D1202%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morshed A.  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Peter A.  Smith</span>, <span class="hlFld-ContribAuthor ">Edward E.  Knaus</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Methodology for the Synthesis of 1-(Trimethylammoniummethyl)cyclohexaneacetic Acid Iodide: A Trimethylammonium Iodide Salt of Gabapentin. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2010,</strong> <em>42 </em>
                                    (1)
                                     , 103-106. <a href="https://doi.org/10.1080/00304940903523991" title="DOI URL">https://doi.org/10.1080/00304940903523991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304940903523991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304940903523991%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DAn%252BEfficient%252BMethodology%252Bfor%252Bthe%252BSynthesis%252Bof%252B1-%252528Trimethylammoniummethyl%252529cyclohexaneacetic%252BAcid%252BIodide%25253A%252BA%252BTrimethylammonium%252BIodide%252BSalt%252Bof%252BGabapentin%26aulast%3DChowdhury%26aufirst%3DMorshed%2BA.%26date%3D2010%26date%3D2010%26volume%3D42%26issue%3D1%26spage%3D103%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena L.  Luzina</span>, <span class="hlFld-ContribAuthor ">Anatoliy V.  Popov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N′-thiazolyl and N-bis(trifluoromethyl)alkyl-N′-benzothiazolyl ureas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>44 </em>
                                    (12)
                                     , 4944-4953. <a href="https://doi.org/10.1016/j.ejmech.2009.08.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2009.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2009.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2009.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252BN-bis%252528trifluoromethyl%252529alkyl-N%2525E2%252580%2525B2-thiazolyl%252Band%252BN-bis%252528trifluoromethyl%252529alkyl-N%2525E2%252580%2525B2-benzothiazolyl%252Bureas%26aulast%3DLuzina%26aufirst%3DElena%2BL.%26date%3D2009%26volume%3D44%26issue%3D12%26spage%3D4944%26epage%3D4953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher I  Fincham</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bressan</span>, <span class="hlFld-ContribAuthor ">Marielle  Paris</span>, <span class="hlFld-ContribAuthor ">Cristina  Rossi</span>, <span class="hlFld-ContribAuthor ">Daniela  Fattori</span>. </span><span class="cited-content_cbyCitation_article-title">Bradykinin receptor antagonists – a review of the patent literature 2005 – 2008. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2009,</strong> <em>19 </em>
                                    (7)
                                     , 919-941. <a href="https://doi.org/10.1517/13543770902994389" title="DOI URL">https://doi.org/10.1517/13543770902994389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543770902994389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543770902994389%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DBradykinin%252Breceptor%252Bantagonists%252B%2525E2%252580%252593%252Ba%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%252B2005%252B%2525E2%252580%252593%252B2008%26aulast%3DFincham%26aufirst%3DChristopher%2BI%26date%3D2009%26date%3D2009%26volume%3D19%26issue%3D7%26spage%3D919%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Benjamin  Cooley</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Kathy D.  Miller</span>, <span class="hlFld-ContribAuthor ">George W.  Sledge</span>, <span class="hlFld-ContribAuthor ">Gary D.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2008,</strong> <em>66 </em>
                                    (10)
                                     , 1406-1413. <a href="https://doi.org/10.1016/j.apradiso.2008.03.010" title="DOI URL">https://doi.org/10.1016/j.apradiso.2008.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2008.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2008.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DSynthesis%252Bof%252Bnew%252Bcarbon-11%252Blabeled%252Bnaphthalene-sulfonamides%252Bfor%252BPET%252Bimaging%252Bof%252Bhuman%252BCCR8%26aulast%3DWang%26aufirst%3DMin%26date%3D2008%26volume%3D66%26issue%3D10%26spage%3D1406%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han Na  Seo</span>, <span class="hlFld-ContribAuthor ">Ja Youn  Choi</span>, <span class="hlFld-ContribAuthor ">Yun Jeong  Choe</span>, <span class="hlFld-ContribAuthor ">Yoonjee  Kim</span>, <span class="hlFld-ContribAuthor ">Hyewhon  Rhim</span>, <span class="hlFld-ContribAuthor ">So Ha  Lee</span>, <span class="hlFld-ContribAuthor ">Jungahn  Kim</span>, <span class="hlFld-ContribAuthor ">Dong Jun  Joo</span>, <span class="hlFld-ContribAuthor ">Jae Yeol  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent T-type calcium channel blocker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (21)
                                     , 5740-5743. <a href="https://doi.org/10.1016/j.bmcl.2007.08.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.08.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.08.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252BT-type%252Bcalcium%252Bchannel%252Bblocker%26aulast%3DSeo%26aufirst%3DHan%2BNa%26date%3D2007%26volume%3D17%26issue%3D21%26spage%3D5740%26epage%3D5743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 In vivo activity of compounds <b>41</b>−<b>46</b> and reference compounds after intratracheal administration at 300 nmol/kg. For details, see the Experimental Section. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kc00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kc00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kc00001.jpeg" id="rightTab-_i6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Competitive, Nonpeptidic hB<sub>2</sub> Receptor Antagonists Anatibant and MEN 15442 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kc00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kc00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00001.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) NBS, AIBN, CCl<sub>4</sub>; (b) amino acid methyl ester, base; (c) amino acid, BSA, TMSCl, THF; (d) 2,4-dimethyl-quinolin-8-ol, KI, base; (e) LiOH, THF/H<sub>2</sub>O or NaOH, THF/H<sub>2</sub>O; (f) HCl/dioxane; (g) HCHO, BH<sub>3</sub>−CN resin, MeOH; (h) Ac<sub>2</sub>O, DIPEA, DMF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00002.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) EDAC, HOAt, R‘CO-piperazine; (b) HOAt or HOBt, EDAC, Boc-piperazine (<b>5a</b>−<b>5c</b>, <b>5e</b>, <b>5f</b>) or Fmoc-piperazine (<b>5d</b>); (c) HCl/dioxane; (d) piperidine, DMF; (e) R‘CO<sub>2</sub>H, EDAC, HOBt, DIPEA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00003.jpeg" id="rightTab-_i11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) HCHO, H<sub>2</sub>, 10% Pd/C, MeOH; (b) <i>O</i>-methyl-<i>N</i>,<i>N</i>‘-diisopropylisourea, MeOH; (c) Me<sub>2</sub>SO<sub>4</sub>, NaOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00004.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) H<sub>2</sub>, 10% Pd/C, MeOH; (b) Goodman's reagent; (c) HCHO, NaCNBH<sub>3</sub>; (d) Fmoc-piperazine, EDAC, HOBt, DIPEA; (e) H<sub>2</sub>, 10% Pd/C, AcOH; (f) MeI; (g) piperidine/DMF; (h) HCl/dioxane.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00005.jpeg" id="rightTab-_i13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) H<sub>2</sub>, 10% Pd/C, MeOH; (b) Me<sub>2</sub>SO<sub>4</sub>, NaOH; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCHO, NaCNBH<sub>3</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00006.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (b) Me<sub>2</sub>SO<sub>4</sub>, NaOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kf00002" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00002.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 In vivo activity of compounds <b>49</b>−<b>67</b> after intratracheal administration at 100 nmol/kg. For details, see the Experimental Section; <b>66</b> and <b>67</b> were tested at 300 nmol/kg. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kh00007" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00007.jpeg" id="rightTab-_i21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Goodman's reagent; (b) DIAD, PPh<sub>3</sub>, 3-dimethylaminopropanol; (c) HCl/dioxane; (d) MeI.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kf00003" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00003.jpeg" id="rightTab-_i23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 In vivo activity of compounds <b>68</b>, <b>70</b>, and <b>72</b> after intratracheal administration at 100 nmol/kg. For details, see the Experimental Section. b = Σ% (BC), bronchoconstriction, see ref 12. c = Σ% (BP), blood pressure, see ref 12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm061143kf00004" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/medium/jm061143kf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00004.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 In vivo activity of compound <b>72</b> after intratracheal administration on bronchoconstriction and hypotension induced by repeated challenges with BK (10 nmol/kg iv) in anaesthetized guinea pigs.<sup>16</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-3/jm061143k/production/images/large/jm061143kf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm061143k&amp;id=jm061143kf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 16 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm061143kb00001"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00001_1"><span><span class="NLM_string-ref">Mak, J. C. W.; Barnes, P. J. Autoradiographic visualization of bradykinin receptors in human and guinea-pig lung. <i>  Eur. J. Pharmacol.</i><b>1991</b>, <i>194</i>, 37−43.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1991&pages=43&author=J.+C.+W.+Mak&author=P.+J+Barnes&title=Autoradiographic+visualization+of+bradykinin+receptors+in+human+and+guinea-pig+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DJ.%2BC.%2BW.%26atitle%3DAutoradiographic%2520visualization%2520of%2520bradykinin%2520receptors%2520in%2520human%2520and%2520guinea-pig%2520lung%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D194%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00002"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00002_1"><span><span class="NLM_string-ref">Dear, J. W.; Wirth, K.; Scadding, G. K.; Foreman, J. C. Characterization of the bradykinin receptor in the human nasal airway using the binding of [<sup>125</sup>I]-Hoe 140. <i>  Br. J. Pharmacol.</i><b>1996</b>, <i>119</i>, 1054−1062.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1062&author=J.+W.+Dear&author=K.+Wirth&author=G.+K.+Scadding&author=J.+C+Foreman&title=Characterization+of+the+bradykinin+receptor+in+the+human+nasal+airway+using+the+binding+of+%5B125I%5D-Hoe+140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDear%26aufirst%3DJ.%2BW.%26atitle%3DCharacterization%2520of%2520the%2520bradykinin%2520receptor%2520in%2520the%2520human%2520nasal%2520airway%2520using%2520the%2520binding%2520of%2520%255B125I%255D-Hoe%2520140%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00003"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00003_1"><span><span class="NLM_string-ref">Polosa, R.; Holgate, S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg<sup>9</sup>]bradykinin in normal and asthmatic subjects.<i> Eur. J. Pharmacol.</i><b>1989</b>, <i>163</i>, 195−197.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1989&pages=197&author=R.+Polosa&author=S.+T+Holgate&title=Comparative+airway+response+to+inhaled+bradykinin%2C+kallidin%2C+and+%5Bdes-Arg9%5Dbradykinin+in+normal+and+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolosa%26aufirst%3DR.%26atitle%3DComparative%2520airway%2520response%2520to%2520inhaled%2520bradykinin%252C%2520kallidin%252C%2520and%2520%255Bdes-Arg9%255Dbradykinin%2520in%2520normal%2520and%2520asthmatic%2520subjects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1989%26volume%3D163%26spage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00004"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00004_1"><span><span class="NLM_string-ref">Churchill, L.; Pongracic, J. A.; Reynolds, C. J.; Naclerio, R. M.; Proud, D. Pharmacology of nasal provocation with bradykinin:  Studies of tachyphylaxis, cyclooxygenase inhibition, α-adrenergic stimulation and receptor subtype. <i>  Int. Arch. Allergy Appl. Immunol.</i><b>1991</b>,<i> 95</i>, 322−331.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1991&pages=331&author=L.+Churchill&author=J.+A.+Pongracic&author=C.+J.+Reynolds&author=R.+M.+Naclerio&author=D+Proud&title=Pharmacology+of+nasal+provocation+with+bradykinin%3A%E2%80%89+Studies+of+tachyphylaxis%2C+cyclooxygenase+inhibition%2C+%CE%B1-adrenergic+stimulation+and+receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChurchill%26aufirst%3DL.%26atitle%3DPharmacology%2520of%2520nasal%2520provocation%2520with%2520bradykinin%253A%25E2%2580%2589%2520Studies%2520of%2520tachyphylaxis%252C%2520cyclooxygenase%2520inhibition%252C%2520%25CE%25B1-adrenergic%2520stimulation%2520and%2520receptor%2520subtype%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Appl.%2520Immunol.%26date%3D1991%26volume%3D95%26spage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00005"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00005_1"><span><span class="NLM_string-ref">Shibayama, Y; Skoner, D.; Suehiro, S.; Konishi, J. E.; Fireman, P.; Kaplan, A. P. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. <i>  Immunopharmacology</i><b>1996</b>, <i>33</i>, 311−313.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=313&author=+Shibayama&author=S.+Suehiro&author=J.+E.+Konishi&author=P.+Fireman&author=A.+P+Kaplan&title=Bradykinin+levels+during+experimental+nasal+infection+with+rhinovirus+and+attenuated+influenza+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShibayama%26atitle%3DBradykinin%2520levels%2520during%2520experimental%2520nasal%2520infection%2520with%2520rhinovirus%2520and%2520attenuated%2520influenza%2520virus%26jtitle%3DImmunopharmacology%26date%3D1996%26volume%3D33%26spage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00006"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00006_1"><span><span class="NLM_string-ref">Svensson, C.; Andresson, M.; Persson, C. G.; Venge, P.; Alkner, U.; Pipkorn, U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.<i> J. Allergy Clin. Immunol.</i><b>1990</b>, <i>85</i>, 828−833.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1990&pages=833&author=C.+Svensson&author=M.+Andresson&author=C.+G.+Persson&author=P.+Venge&author=U.+Alkner&author=U.+Pipkorn&author=+Albumin&title=and+eosinophil+cationic+protein+on+the+nasal+mucosal+surface+in+patients+with+hay+fever+during+natural+allergen+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%26atitle%3Dand%2520eosinophil%2520cationic%2520protein%2520on%2520the%2520nasal%2520mucosal%2520surface%2520in%2520patients%2520with%2520hay%2520fever%2520during%2520natural%2520allergen%2520exposure%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D1990%26volume%3D85%26spage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00007"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00007_1"><span><span class="NLM_string-ref">Akbary, A. M.; Wirth, K. J.; Scholkens, B. A. Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. <i>  Immunopharmacology</i><b>1996</b>, <i>33</i>, 238−242.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=242&author=A.+M.+Akbary&author=K.+J.+Wirth&author=B.+A+Scholkens&title=Efficacy+and+tolerability+of+Icatibant+%28Hoe+140%29+in+patients+with+moderately+severe+chronic+bronchial+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkbary%26aufirst%3DA.%2BM.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520Icatibant%2520%2528Hoe%2520140%2529%2520in%2520patients%2520with%2520moderately%2520severe%2520chronic%2520bronchial%2520asthma%26jtitle%3DImmunopharmacology%26date%3D1996%26volume%3D33%26spage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00008"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00008_1"><span><span class="NLM_string-ref">Austin, C. E.; Foreman, J. C.; Scadding, G. K. Reduction by Hoe 140, the B<sub>2</sub> kinin receptor antagonist, of antigen-induced nasal blockage.<i> Br. J. </i><i>Pharmacol.</i><b>1994</b>, <i>111</i>, 969−971.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1994&pages=971&author=C.+E.+Austin&author=J.+C.+Foreman&author=G.+K+Scadding&title=Reduction+by+Hoe+140%2C+the+B2+kinin+receptor+antagonist%2C+of+antigen-induced+nasal+blockage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DC.%2BE.%26atitle%3DReduction%2520by%2520Hoe%2520140%252C%2520the%2520B2%2520kinin%2520receptor%2520antagonist%252C%2520of%2520antigen-induced%2520nasal%2520blockage%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D111%26spage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00009"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00009_1"><span><span class="NLM_string-ref">Kuoppala, A.; Lindsted, K. A.; Saarinen, J.; Kovanen, P. T.; Kokkonen, J. O. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. <i>  Am. J. Physiol.</i><b>2000</b>, <i>278 </i>(4), H1069−1074.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2000&pages=1074&issue=4&author=A.+Kuoppala&author=K.+A.+Lindsted&author=J.+Saarinen&author=P.+T.+Kovanen&author=J.+O+Kokkonen&title=Inactivation+of+bradykinin+by+angiotensin-converting+enzyme+and+by+carboxypeptidase+N+in+human+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuoppala%26aufirst%3DA.%26atitle%3DInactivation%2520of%2520bradykinin%2520by%2520angiotensin-converting%2520enzyme%2520and%2520by%2520carboxypeptidase%2520N%2520in%2520human%2520plasma%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2000%26volume%3D278%26issue%3D4%26spage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm061143kb00010_1"><span><span class="NLM_string-ref">Campbell, D. J.; Krum, H.; Esler, M. D. Losartan increases bradykinin levels in hypertensive humans. <i>  Circulation</i><b>2005</b>, <i>111</i>, 315−320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=320&author=D.+J.+Campbell&author=H.+Krum&author=M.+D+Esler&title=Losartan+increases+bradykinin+levels+in+hypertensive+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DD.%2BJ.%26atitle%3DLosartan%2520increases%2520bradykinin%2520levels%2520in%2520hypertensive%2520humans%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00011"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00011_1"><span><span class="NLM_string-ref">Fattori, D.; Rossi, C.; Fincham, C. I.; Berettoni, M.; Calvani, F.; Catrambone, F.; Felicetti, P.; Gensini, M.; Terracciano, R.; Altamura, M.; Bressan, A.; Giuliani, S.; Maggi, C. A.; Meini, S.; Valenti, C.; Quartara, L. Design and synthesis of novel sulfonamide-containing bradykinin hB<sub>2</sub> receptor antagonists. 1. Synthesis and SAR of α,α-dimethylglycine sulfonamides.<i> J. Med. Chem.</i><b>2006</b>, <i>49</i>, 3602−3613.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3613&author=D.+Fattori&author=C.+Rossi&author=C.+I.+Fincham&author=M.+Berettoni&author=F.+Calvani&author=F.+Catrambone&author=P.+Felicetti&author=M.+Gensini&author=R.+Terracciano&author=M.+Altamura&author=A.+Bressan&author=S.+Giuliani&author=C.+A.+Maggi&author=S.+Meini&author=C.+Valenti&author=L+Quartara&title=Design+and+synthesis+of+novel+sulfonamide-containing+bradykinin+hB2+receptor+antagonists.+1.+Synthesis+and+SAR+of+%CE%B1%2C%CE%B1-dimethylglycine+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFattori%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520sulfonamide-containing%2520bradykinin%2520hB2%2520receptor%2520antagonists.%25201.%2520Synthesis%2520and%2520SAR%2520of%2520%25CE%25B1%252C%25CE%25B1-dimethylglycine%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00012"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00012_1"><span><span class="NLM_string-ref">Sum of residual BK-induced response calculated in percentage with respect to the basal response and normalized in comparison to the control registered at the various times of observation (5−30−60−90−120−180−210 min), further calculated in percentages with respect to the theoretical maximum. As a consequence, the maximal inhibition that may be obtained corresponds to Σ% = 0, while the absence of inhibition corresponds to Σ% = 100.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Sum+of+residual+BK-induced+response+calculated+in+percentage+with+respect+to+the+basal+response+and+normalized+in+comparison+to+the+control+registered+at+the+various+times+of+observation+%285%E2%88%9230%E2%88%9260%E2%88%9290%E2%88%92120%E2%88%92180%E2%88%92210+min%29%2C+further+calculated+in+percentages+with+respect+to+the+theoretical+maximum.+As+a+consequence%2C+the+maximal+inhibition+that+may+be+obtained+corresponds+to+%CE%A3%25+%3D+0%2C+while+the+absence+of+inhibition+corresponds+to+%CE%A3%25+%3D+100.+Sum+of+residual+BK-induced+response+calculated+in+percentage+with+respect+to+the+basal+response+and+normalized+in+comparison+to+the+control+registered+at+the+various+times+of+observation+%285%E2%88%9230%E2%88%9260%E2%88%9290%E2%88%92120%E2%88%92180%E2%88%92210+min%29%2C+further+calculated+in+percentages+with+respect+to+the+theoretical+maximum.+As+a+consequence%2C+the+maximal+inhibition+that+may+be+obtained+corresponds+to+%CE%A3%25+%3D+0%2C+while+the+absence+of+inhibition+corresponds+to+%CE%A3%25+%3D+100."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00013"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00013_1"><span><span class="NLM_string-ref">Cucchi, P.; Meini, S.; Bressan, A.; Catalani, C.; Bellucci, F.; Santicioli, P.; Lecci, A.; Faiella, A.; Rotondaro, L.; Giuliani, S.; Giolitti, A.; Quartara, L.; Maggi, C. A. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. <i>  Eur. J. Pharmacol.</i><b>2005</b>, <i>528</i>, 7−16.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=528&publication_year=2005&pages=16&author=P.+Cucchi&author=S.+Meini&author=A.+Bressan&author=C.+Catalani&author=F.+Bellucci&author=P.+Santicioli&author=A.+Lecci&author=A.+Faiella&author=L.+Rotondaro&author=S.+Giuliani&author=A.+Giolitti&author=L.+Quartara&author=C.+A.+Maggi&title=a+novel+potent+and+selective+nonpeptide+antagonist+for+the+human+bradykinin+B2+receptor.+In+vitro+pharmacology+and+molecular+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCucchi%26aufirst%3DP.%26atitle%3Da%2520novel%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520for%2520the%2520human%2520bradykinin%2520B2%2520receptor.%2520In%2520vitro%2520pharmacology%2520and%2520molecular%2520characterization%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D528%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00014"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00014_1"><span><span class="NLM_string-ref">(a) McAllistar, S. M.; Alpar, H. O.; Teitelbaum, Z.; Bennet, D. B. Do interactions with phospholipids contribute to the prolonged retention of polypeptides within lungs? <i>Adv. Drug Delivery Rev.</i><b>1996</b>, <i>19</i>, 89−110.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=110&author=S.+M.+McAllistar&author=H.+O.+Alpar&author=Z.+Teitelbaum&author=D.+B+Bennet&title=Do+interactions+with+phospholipids+contribute+to+the+prolonged+retention+of+polypeptides+within+lungs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllistar%26aufirst%3DS.%2BM.%26atitle%3DDo%2520interactions%2520with%2520phospholipids%2520contribute%2520to%2520the%2520prolonged%2520retention%2520of%2520polypeptides%2520within%2520lungs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1996%26volume%3D19%26spage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm061143kb00014_2"><span><span class="NLM_string-ref">(b) Upton, R. N.; Doolette, D. J. Kinetic aspects of drug disposition in the lungs. <i>  Clin. Exp. Pharmacol. Physiol.</i><b>1999</b>, <i>26</i>, 381−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=391&author=R.+N.+Upton&author=D.+J+Doolette&title=Kinetic+aspects+of+drug+disposition+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00014_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUpton%26aufirst%3DR.%2BN.%26atitle%3DKinetic%2520aspects%2520of%2520drug%2520disposition%2520in%2520the%2520lungs%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1999%26volume%3D26%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00015"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00015_1"><span><span class="NLM_string-ref">Barnes, P. G. Tiotropium Bromide. <i>  Exp. Opin. Inv. Drugs</i><b>2001</b>, <i>10</i>, 733−740.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Barnes%2C+P.+G.+Tiotropium+Bromide.+Exp.+Opin.+Inv.+Drugs+2001%2C+10%2C+733%E2%88%92740.+Barnes%2C+P.+G.+Tiotropium+Bromide.+Exp.+Opin.+Inv.+Drugs2001%2C+10%2C+733%E2%88%92740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BG.%26jtitle%3DExp.%2520Opin.%2520Inv.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm061143kb00016"><div class="reference"><strong class="refLabel"><a href="#jm061143kb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm061143kb00016_1"><span><span class="NLM_string-ref">Valenti, C.; Cialdai, C.; Giuliani, S.; Lecci, A.; Tramontana, M.; Meini, S.; Quartara, L.; Maggi, C. A. MEN 16132, a novel, potent and selective non-peptide kinin B<sub>2</sub> receptor antagonist. In vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs. <i>  J. Pharmacol. Exp. Ther.</i><b>2005</b>, 616−623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=616&publication_year=2005&pages=623&author=C.+Valenti&author=C.+Cialdai&author=S.+Giuliani&author=A.+Lecci&author=M.+Tramontana&author=S.+Meini&author=L.+Quartara&author=C.+A.+Maggi&title=potent+and+selective+non-peptide+kinin+B2+receptor+antagonist.+In+vivo+activity+on+bradykinin-induced+bronchoconstriction+and+nasal+mucosa+microvascular+leakage+in+anesthetized+guinea+pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm061143kb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DC.%26atitle%3Dpotent%2520and%2520selective%2520non-peptide%2520kinin%2520B2%2520receptor%2520antagonist.%2520In%2520vivo%2520activity%2520on%2520bradykinin-induced%2520bronchoconstriction%2520and%2520nasal%2520mucosa%2520microvascular%2520leakage%2520in%2520anesthetized%2520guinea%2520pigs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D616%26spage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm061143k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm061143k%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-3" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm061143k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                522KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b5e8a92f3db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
